Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________________________

FORM 10-Q

___________________________________________

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 31, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number: 001-40348

___________________________________________

UiPath, Inc.

(Exact Name of Registrant as Specified in its Charter)

___________________________________________


Delaware			47-4333187
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
One Vanderbilt Avenue, 60th Floor New York, New York			10017
(Address of principal executive offices)			(Zip Code)
Registrant’s telephone number, including area code: (844) 432-0455

___________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of each exchange on which registered

Class A common stock, par value
$0.00001 per share

PATH

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of September 3, 2024, the registrant had 467,504,776 shares of Class A common stock and 82,452,748 shares of Class B common stock, each with a par value of $0.00001 per share, outstanding.

Table of Contents


		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Statements of Comprehensive Loss	3
	Condensed Consolidated Statements of Stockholders’ Equity	4
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	40
Item 4.	Controls and Procedures	41

PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	42
Item 1A.	Risk Factors	42
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	43
Item 3.	Defaults Upon Senior Securities	44
Item 4.	Mine Safety Disclosures	44
Item 5.	Other Information	45
Item 6.	Exhibits	46
Signatures		47

Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), about UiPath, Inc. and its consolidated subsidiaries (“UiPath,” the “Company,” “we,” “us,” or “our”) and our industry that involve substantial risks and uncertainties. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations or financial condition, business strategy, and plans and objectives of management for future operations, are forward-looking statements. In some cases, forward-looking statements can be identified because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements concerning the following:

•our expectations regarding our revenue, annualized renewal run-rate ("ARR"), expenses, and other operating results;

•our ability to effectively manage our growth and achieve or sustain profitability;

•our ability to acquire new customers and successfully retain existing customers;

•the ability of the UiPath Business Automation Platform to satisfy and adapt to customer demands and our ability to increase its adoption;

•our ability to grow our platform and release new functionality in a timely manner;

•future investments in our business, our anticipated capital expenditures, and our estimates regarding our capital requirements;

•the costs and success of our marketing efforts and our ability to evolve and enhance our brand;

•our growth strategies;

•the estimated addressable market opportunity for our platform and for automation in general;

•our reliance on key personnel and our ability to attract, integrate, and retain highly-qualified personnel and execute management transitions, including our Chief Executive Officer ("CEO") transition;

•our ability to obtain, maintain, and enforce our intellectual property rights and any costs associated therewith;

•the effect of significant events with macroeconomic impacts, including but not limited to military conflicts and other changes in geopolitical relationships and inflationary cost trends, on our business, industry, and the global economy;

•our reliance on third-party providers of cloud-based infrastructure;

•our ability to compete effectively with existing competitors and new market entrants, including new, potentially disruptive technologies;

•the size and growth rates of the markets in which we compete; and

•the price volatility of our Class A common stock.

These forward-looking statements should not be unduly relied upon or regarded as predictions of future events. The forward-looking statements contained in this Quarterly Report on Form 10-Q are based on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled "Risk Factors" and elsewhere in this Quarterly Report on Form 10-Q, and in the section titled "Risk Factors" and elsewhere in our Annual Report on Form 10-K for the fiscal year ended January 31, 2024 filed with the Securities and Exchange Commission ("SEC") on March 27, 2024 (the "2024 Form 10-K"). Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.

In addition, statements that “we believe,” and similar statements reflect our beliefs and opinions on the relevant subject, based on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe such information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. Such statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.

The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments.

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited).

UiPath, Inc.

Condensed Consolidated Balance Sheets

Amounts in thousands except per share data

(unaudited)


	As of
	July 31, 2024		January 31, 2024
ASSETS
Current assets
Cash and cash equivalents	$	939,313	$	1,061,678
Restricted cash	438		438
Marketable securities	804,061		818,145
Accounts receivable, net of allowance for credit losses of $2,164 and $1,119, respectively	267,706		436,296
Contract assets	101,107		84,197
Deferred contract acquisition costs	76,653		74,678
Prepaid expenses and other current assets	85,056		104,980
Total current assets	2,274,334		2,580,412

Contract assets, non-current	9,232		6,214
Deferred contract acquisition costs, non-current	146,564		154,317
Property and equipment, net	22,040		23,982
Operating lease right-of-use assets	71,033		56,072
Intangible assets, net	11,025		14,704
Goodwill	89,530		89,026
Deferred tax assets	3,763		4,678
Other assets, non-current	73,812		25,353
Total assets	$	2,701,333	$	2,954,758
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable	$	9,910	$	3,447
Accrued expenses and other current liabilities	82,640		83,997
Accrued compensation and employee benefits	77,444		137,442
Deferred revenue	462,509		486,805
Total current liabilities	632,503		711,691
Deferred revenue, non-current	150,346		161,027
Operating lease liabilities, non-current	78,166		58,713
Other liabilities, non-current	6,737		7,213
Total liabilities	867,752		938,644
Commitments and contingencies (Note 9)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding	—		—
Class A common stock, $0.00001 par value per share, 2,000,000 shares authorized; 501,162 and 492,660 shares issued; 478,058 and 486,820 shares outstanding, respectively	5		5
Class B common stock, $0.00001 par value per share, 115,741 shares authorized; 82,453 shares issued and outstanding	1		1
Treasury stock, at cost, 23,104 and 5,840 shares, respectively	(322,047)		(102,615)
Additional paid-in capital	4,176,531		4,024,079
Accumulated other comprehensive income	8,105		8,825
Accumulated deficit	(2,029,014)		(1,914,181)
Total stockholders’ equity	1,833,581		2,016,114
Total liabilities and stockholders’ equity	$	2,701,333	$	2,954,758

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

UiPath, Inc.

Condensed Consolidated Statements of Operations

Amounts in thousands except per share data

(unaudited)


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Revenue:
Licenses	$	112,251	$	119,300	$	252,379	$	253,339
Subscription services	194,673		159,999		379,804		306,351
Professional services and other	9,329		8,011		19,182		17,208
Total revenue	316,253		287,310		651,365		576,898
Cost of revenue:
Licenses	2,393		3,008		4,994		5,555
Subscription services	43,529		26,777		80,283		49,855
Professional services and other	17,398		19,202		33,368		37,244
Total cost of revenue	63,320		48,987		118,645		92,654
Gross profit	252,933		238,323		532,720		484,244
Operating expenses:
Sales and marketing	194,330		169,725		374,469		330,131
Research and development	98,433		86,606		184,036		161,948
General and administrative	63,519		59,577		127,029		116,161
Total operating expenses	356,282		315,908		685,534		608,240
Operating loss	(103,349)		(77,585)		(152,814)		(123,996)
Interest income	13,370		13,582		27,200		27,430
Other income, net	7,710		7,472		18,389		11,766
Loss before income taxes	(82,269)		(56,531)		(107,225)		(84,800)
Provision for income taxes	3,828		3,830		7,608		7,462
Net loss	$	(86,097)	$	(60,361)	$	(114,833)	$	(92,262)


Net loss per share, basic and diluted	$	(0.15)	$	(0.11)	$	(0.20)	$	(0.16)
Weighted-average shares used in computing net loss per share, basic and diluted	568,042		562,883		568,973		560,422

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

UiPath, Inc.

Condensed Consolidated Statements of Comprehensive Loss

Amounts in thousands

(unaudited)


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Net loss	$	(86,097)	$	(60,361)	$	(114,833)	$	(92,262)
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale marketable securities, net	482		(161)		(29)		(18)
Foreign currency translation adjustments	2,883		1,593		(691)		3,912
Other comprehensive income (loss), net	3,365		1,432		(720)		3,894
Comprehensive loss	$	(82,732)	$	(58,929)	$	(115,553)	$	(88,368)

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

UiPath, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

Amounts in thousands

(unaudited)


	Common Stock						Treasury Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total Stockholders’ Equity
	Class A			Class B
	Shares	Amount		Shares	Amount		Shares	Amount		Amount		Amount		Amount		Amount
Balance as of January 31, 2024	492,660	$	5	82,453	$	1	(5,840)	$	(102,615)	$	4,024,079	$	8,825	$	(1,914,181)	$	2,016,114
Issuance of common stock upon exercise of stock options	1,426	—		—	—		—	—		311		—		—		311

Issuance of common stock upon settlement of restricted stock units	3,843	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(1,317)	—		—	—		—	—		(29,944)		—		—		(29,944)
Charitable donation of Class A common stock	281	—		—	—		—	—		6,564		—		—		6,564
Repurchase of Class A Common Stock	—	—		—	—		(938)	(22,005)		—		—		—		(22,005)
Stock-based compensation	—	—		—	—		—	—		88,785		—		—		88,785
Other comprehensive loss, net	—	—		—	—		—	—		—		(4,085)		—		(4,085)
Net loss	—	—		—	—		—	—		—		—		(28,736)		(28,736)
Balance as of April 30, 2024	496,893	$	5	82,453	$	1	(6,778)	$	(124,620)	$	4,089,795	$	4,740	$	(1,942,917)	$	2,027,004
Issuance of common stock upon exercise of stock options	727	—		—	—		—	—		331		—		—		331
Issuance of common stock upon settlement of restricted stock units	3,970	—		—	—		—	—		—		—		—		—
Vesting of early exercised stock options	—	—		—	—		—	—		1		—		—		1
Tax withholdings on settlement of restricted stock units	(1,293)	—		—	—		—	—		(16,727)		—		—		(16,727)
Repurchase of Class A Common Stock	—	—		—	—		(16,326)	(197,427)		—		—		—		(197,427)
Issuance of common stock under employee stock purchase plan	865	—		—	—		—	—		8,824		—		—		8,824
Stock-based compensation	—	—		—	—		—	—		94,307		—		—		94,307
Other comprehensive income, net	—	—		—	—		—	—		—		3,365		—		3,365
Net loss	—	—		—	—		—	—		—		—		(86,097)		(86,097)
Balance as of July 31, 2024	501,162	$	5	82,453	$	1	(23,104)	$	(322,047)	$	4,176,531	$	8,105	$	(2,029,014)	$	1,833,581

Table of Contents


	Common Stock						Treasury Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income		Accumulated Deficit		Total Stockholders’ Equity
	Class A			Class B
	Shares	Amount		Shares	Amount		Shares	Amount		Amount		Amount		Amount		Amount
Balance as of January 31, 2023	474,160	$	5	82,453	$	1	—	$	—	$	3,736,838	$	7,612	$	(1,824,298)	$	1,920,158
Issuance of common stock upon exercise of stock options	898	—		—	—		—	—		1,175		—		—		1,175
Issuance of common stock upon settlement of restricted stock units	4,246	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(1,463)	—		—	—		—	—		(25,697)		—		—		(25,697)
Charitable donations of Class A common stock	281	—		—	—		—	—		4,215		—		—		4,215
Stock-based compensation	—	—		—	—		—	—		85,125		—		—		85,125
Other comprehensive income, net	—	—		—	—		—	—		—		2,462		—		2,462
Net loss	—	—		—	—		—	—		—		—		(31,901)		(31,901)
Balance as of Balance as of April 30, 2023	478,122	$	5	82,453	$	1	—	$	—	$	3,801,656	$	10,074	$	(1,856,199)	$	1,955,537
Issuance of common stock upon exercise of stock options	1,824	—		—	—		—	—		2,717		—		—		2,717
Issuance of common stock upon settlement of restricted stock units	5,026	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(1,676)	—		—	—		—	—		(27,420)		—		—		(27,420)
Issuance of common stock under employee stock purchase plan	832	—		—	—		—	—		9,313		—		—		9,313
Stock-based compensation	—	—		—	—		—	—		102,148		—		—		102,148
Other comprehensive income, net	—	—		—	—		—	—		—		1,432		—		1,432
Net loss	—	—		—	—		—	—		—		—		(60,361)		(60,361)
Balance as of July 31, 2023	484,128	$	5	82,453	$	1	—	$	—	$	3,888,414	$	11,506	$	(1,916,560)	$	1,983,366

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

UiPath, Inc.

Condensed Consolidated Statements of Cash Flows

Amounts in thousands

(unaudited)


	Six Months Ended July 31,
	2024		2023
Cash flows from operating activities
Net loss	$	(114,833)	$	(92,262)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	9,483		11,160
Amortization of deferred contract acquisition costs	39,392		31,229
Net amortization on marketable securities	(18,527)		(10,745)
Stock-based compensation expense	183,032		187,145
Charitable donation of Class A common stock	6,564		4,215
Non-cash operating lease expense	7,562		6,299
Provision for deferred income taxes	752		(57)

Other non-cash (credits) charges, net	(573)		965
Changes in operating assets and liabilities:
Accounts receivable	165,781		147,725
Contract assets	(19,773)		(9,455)
Deferred contract acquisition costs	(33,898)		(36,389)
Prepaid expenses and other assets	6,314		(6,679)
Accounts payable	6,774		(6,033)
Accrued expenses and other liabilities	7,018		(4,229)
Accrued compensation and employee benefits	(59,799)		(74,184)
Operating lease liabilities, net	(6,983)		(7,532)
Deferred revenue	(31,873)		(29,547)
Net cash provided by operating activities	146,413		111,626
Cash flows from investing activities
Purchases of marketable securities	(697,765)		(709,199)

Maturities of marketable securities	730,337		338,644
Purchases of property and equipment	(2,656)		(2,876)
Purchases of investments	(35,809)		—
Other investing, net	—		2,754
Net cash used in investing activities	(5,893)		(370,677)
Cash flows from financing activities
Repurchases of Class A common stock	(218,752)		—
Proceeds from exercise of stock options	643		3,904
Payments of tax withholdings on net settlement of equity awards	(45,949)		(52,832)
Net receipts (payments) of tax withholdings on sell-to-cover equity award transactions	99		(679)
Proceeds from employee stock purchase plan contributions	8,642		9,643
Payment of deferred consideration related to business acquisition	(5,570)		(5,863)

Net cash used in financing activities	(260,887)		(45,827)
Effect of exchange rate changes	(1,998)		(2,943)
Net decrease in cash, cash equivalents, and restricted cash	(122,365)		(307,821)
Cash, cash equivalents, and restricted cash - beginning of period	1,062,116		1,402,119
Cash, cash equivalents, and restricted cash - end of period	$	939,751	$	1,094,298
Supplemental disclosure of cash flow information
Cash paid for interest	$	309	$	413
Cash paid for income taxes	12,054		7,234
Supplemental disclosure of non-cash investing and financing activities


Property and equipment purchases included in accounts payable	149		—


Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	4,069		2,466

The accompanying notes are an integral part of these consolidated financial statements.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements

(unaudited)

1. Organization and Description of Business

Description of Business

UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our AI-powered UiPath Business Automation Platform offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale.

2. Summary of Significant Accounting Policies

Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies, in the notes to consolidated financial statements included in the 2024 Form 10-K. There have been no significant changes to such policies during the six months ended July 31, 2024.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2024, which are included in the 2024 Form 10-K.

The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation.

The results of operations for the six months ended July 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2025 or for any other future interim or annual period.

Fiscal Year

Our fiscal year ends on January 31. References to fiscal year 2025, for example, refer to the fiscal year ending January 31, 2025.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Foreign Currency

The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income, net in the condensed consolidated statements of operations. For the three months ended July 31, 2024 and 2023, we recognized foreign currency transaction losses of $(0.6) million and $(0.6) million, respectively. For the six months ended July 31, 2024 and 2023, we recognized foreign currency transaction gains (losses) of $2.2 million and $(1.4) million, respectively.

Concentration of Risks

Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable.

We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of July 31, 2024 and January 31, 2024, 90% and 91%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan.

The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints.

With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three and six months ended July 31, 2024 and 2023, no single customer accounted for 10% or more of our total revenue. As of July 31, 2024 and January 31, 2024, no single customer accounted for 10% or more of our accounts receivable.

Recently Issued Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU No. 2023-09 will require additional tax disclosures, predominantly related to the effective income tax rate reconciliation and income taxes paid. ASU No. 2023-09 will be effective for us for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

3. Revenue Recognition

Disaggregation of Revenue

The following tables summarize revenue by geographical region (dollars in thousands):


	Three Months Ended July 31,
	2024				2023
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	150,591	48	%	$	139,718	49	%
Europe, Middle East, and Africa	97,989		31	%	81,009		28	%
Asia-Pacific (2)	67,673		21	%	66,583		23	%
Total revenue	$	316,253	100	%	$	287,310	100	%

(1)Revenue from the U.S. represented 43% and 44% of our total revenues for the three months ended July 31, 2024 and 2023, respectively.

(2)Revenue from Japan represented 9% and 10% of our total revenues for the three months ended July 31, 2024 and 2023, respectively.


	Six Months Ended July 31,
	2024				2023
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	303,702	47	%	$	263,170	46	%
Europe, Middle East, and Africa	202,616		31	%	177,940		31	%
Asia-Pacific (2)	145,047		22	%	135,788		23	%
Total revenue	$	651,365	100	%	$	576,898	100	%

(1)Revenue from the U.S. represented 42% and 41% of our total revenues for the six months ended July 31, 2024 and 2023, respectively.

(2)Revenue from Japan represented 11% and 11% of our total revenues for the six months ended July 31, 2024 and 2023, respectively.

Deferred Revenue

During the six months ended July 31, 2024 and 2023, we recognized $309.0 million and $254.8 million of revenue that was included in the deferred revenue balance as of January 31, 2024 and 2023, respectively.

Remaining Performance Obligations

Our remaining performance obligations are comprised of licenses, subscription services, and professional services and other revenue not yet delivered. As of July 31, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations was $1,081.3 million, which consists of $612.9 million of billed consideration and $468.4 million of unbilled consideration. We expect to recognize 63% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter.

Deferred Contract Acquisition Costs

Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $20.9 million and $17.1 million for the three months ended July 31, 2024, and 2023, respectively, and $39.4 million and $31.2 million for the six months ended July 31, 2024 and 2023, respectively, and is recorded in sales and marketing expense in the condensed consolidated statements of operations.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

4. Marketable Securities

The following is a summary of our marketable securities (in thousands):


	As of July 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	3,896	$	—	$	—	$	3,896
Treasury bills and U.S. government securities(1)	684,481		23		(102)		684,402
Corporate bonds	93,974		—		(39)		93,935

Agency bonds	21,839		—		(11)		21,828
Total marketable securities	$	804,190	$	23	$	(152)	$	804,061
(1) Additional treasury bills with both amortized cost and estimated fair value of $29.9 million are included in cash and cash equivalents due to their original maturity of three months or less.


	As of January 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value

Treasury bills and U.S. government securities	641,263		29		(100)		641,192
Corporate bonds	1,993		—		(2)		1,991

Agency bonds	174,990		—		(28)		174,962
Total marketable securities	$	818,246	$	29	$	(130)	$	818,145

As of July 31, 2024 and January 31, 2024, none of our marketable securities had remaining contractual maturities of one year or more.

As of July 31, 2024 and January 31, 2024, $3.6 million and $3.3 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of July 31, 2024 and January 31, 2024.

Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.

5. Fair Value Measurement

The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of July 31, 2024 and January 31, 2024 (in thousands):


	As of July 31, 2024
	Level 1		Level 2		Level 3		Total

Money market	$	407,805	$	—	$	—	$	407,805
Treasury bills	29,886		—		—		29,886


Total cash equivalents	437,691		—		—		437,691
Commercial paper	—		3,896		—		3,896
Treasury bills and U.S. government securities	684,402		—		—		684,402
Corporate bonds	—		93,935		—		93,935

Agency bonds	21,828		—		—		21,828
Total marketable securities	706,230		97,831		—		804,061
Other investments carried at fair value	—		—		12,074		12,074
Total	$	1,143,921	$	97,831	$	12,074	$	1,253,826

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)


	As of January 31, 2024
	Level 1		Level 2		Level 3		Total

Money market	$	509,053	$	—	$	—	$	509,053

Total cash equivalents	509,053		—		—		509,053

Treasury bills and U.S. government securities	641,192		—		—		641,192
Corporate bonds	—		1,991		—		1,991

Agency bonds	174,962		—		—		174,962
Total marketable securities	816,154		1,991		—		818,145
Total	$	1,325,207	$	1,991	$	—	$	1,327,198

Our money market funds, treasury bills and U.S. government securities, and agency bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify commercial paper and corporate bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. Other investments carried at fair value, which consist of convertible bonds of private company H.AI (the "H company") purchased during the three months ended July 31, 2024, are classified as Level 3 because their valuation relies on significant unobservable inputs. None of our financial instruments were classified in the Level 3 category as of January 31, 2024.

6. Intangible Assets and Goodwill

Intangible Assets, Net

Acquired intangible assets, net consisted of the following as of July 31, 2024 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,954	$	(19,793)	$	9,161	2.5
Customer relationships	8,312		(7,181)		1,131		1.0
Trade names and trademarks	271		(271)		—		0.0
Other intangibles	1,231		(498)		733		6.7
Total	$	38,768	$	(27,743)	$	11,025

Acquired intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,807	$	(16,881)	$	11,926	2.8
Customer relationships	8,266		(6,306)		1,960		1.3
Trade names and trademarks	272		(266)		6		0.2
Other intangibles	1,231		(419)		812		7.0
Total	$	38,576	$	(23,872)	$	14,704

We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, trade names and trademarks in sales and marketing expense, customer relationships in sales and marketing expense, and other intangibles in general and administrative expense in the condensed consolidated statements of operations. Amortization of acquired intangible assets was $1.8 million and $2.2 million for the three months ended July 31, 2024 and 2023, respectively, and $3.8 million and $4.3 million for the six months ended July 31, 2024 and 2023, respectively.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Expected future amortization expense related to intangible assets was as follows as of July 31, 2024 (in thousands):


	Amount
Remainder of year ending January 31, 2025	$	2,925
Year ending January 31,
2026	4,142
2027	2,478
2028	1,178
2029	101
Thereafter	201
Total	$	11,025

Goodwill

Changes in the carrying amount of goodwill during the six months ended July 31, 2024 were as follows (in thousands):


	Carrying Amount
Balance as of January 31, 2024	$	89,026

Effect of foreign currency translation	504
Balance as of July 31, 2024	$	89,530

7. Operating Leases

Our operating leases consist of real estate and vehicles and have remaining lease terms of one year to 14 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees.

Lease costs are presented below (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Operating lease cost	$	4,086	$	3,228	$	7,562	$	6,299
Short-term lease cost	1,024		1,320		2,147		2,620
Variable lease cost	411		525		934		1,146
Sublease income (1)	—		(533)		—		(1,065)
Total	$	5,521	$	4,540	$	10,643	$	9,000

(1) Included in other income, net in the condensed consolidated statements of operations.

The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:


	As of
	July 31, 2024		January 31, 2024
Weighted-average remaining lease term (years)	10.4		10.7
Weighted-average discount rate	7.7	%	7.1	%

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Future undiscounted lease payments for our operating lease liabilities as of July 31, 2024 were as follows (in thousands):


	Amount
Remainder of year ending January 31, 2025	$	2,369
Year ending January 31,
2026	14,504
2027	14,367
2028	12,979
2029	9,661
Thereafter	65,646
Total operating lease payments	119,526
Less: imputed interest	(36,922)
Total operating lease liabilities	$	82,604

As of July 31, 2024, we had non-cancellable commitments in the amount of $0.8 million related to operating leases of real estate facilities that have not yet commenced.

Current operating lease liabilities of $4.4 million and $8.4 million were included in accrued expenses and other current liabilities on our condensed consolidated balance sheets as of July 31, 2024 and January 31, 2024, respectively.

Supplemental cash flow information related to leases for the three and six months ended July 31, 2024 and 2023 was as follows (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Cash paid for amounts included in the measurement of operating lease liabilities	$	3,665	$	3,545	$	7,318	$	6,160
Operating lease ROU assets obtained in exchange for new operating lease liabilities	12,748		2,688		19,792		4,681

8. Condensed Consolidated Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of
	July 31, 2024		January 31, 2024
Prepaid expenses and service credits	$	59,363	$	87,781
Other current assets	25,693		17,199
Prepaid expenses and other current assets	$	85,056	$	104,980

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of
	July 31, 2024		January 31, 2024
Computers and equipment	$	23,976	$	23,767
Leasehold improvements	26,262		21,756
Furniture and fixtures	6,931		6,640
Construction in progress	1,727		4,560
Other	644		632
Property and equipment, gross	59,540		57,355
Less: accumulated depreciation	(37,500)		(33,373)
Property and equipment, net	$	22,040	$	23,982

Depreciation expense for the three months ended July 31, 2024 and 2023 was $2.3 million and $2.8 million, respectively. Depreciation expense for the six months ended July 31, 2024 and 2023 was $4.6 million and $5.8 million, respectively.

Other Assets, Non-Current

As of July 31, 2024 and January 31, 2024, other assets, non-current included $25.4 million and $1.5 million, respectively, related to equity investments in private companies without readily determinable fair values. As a measurement alternative, these investments are reported at cost and are assessed periodically to determine whether their carrying value must be adjusted for observable changes in price or indicators of impairment.

As of July 31, 2024, other assets, non-current also included $12.1 million related to private-company convertible bonds, which are carried at fair value. Refer to Note 5, Fair Value Measurement for further information.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	As of
	July 31, 2024		January 31, 2024
Accrued expenses	$	34,700	$	18,458
Withholding tax from employee equity transactions	4,100		3,277
Employee stock purchase plan withholdings	3,408		3,618
Payroll taxes and other benefits payable	7,898		3,888
Income taxes payable	7,406		7,140
Value-added taxes payable	655		6,480
Operating lease liabilities, current	4,438		8,357
Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (paid July 29, 2024)	—		5,570
Rebates payable to partners	7,817		7,289
Other	12,218		19,920
Accrued expenses and other current liabilities	$	82,640	$	83,997

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

9. Commitments and Contingencies

Letters of Credit

We had a total of $2.8 million and $2.6 million in letters of credit outstanding in favor of certain landlords for office space as of July 31, 2024 and January 31, 2024, respectively. These letters of credit renew annually and expire on various dates through fiscal year 2026.

Indemnification

In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties.

These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of July 31, 2024 and January 31, 2024, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements was remote.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Workforce Restructuring

On July 8, 2024, our board of directors approved restructuring actions to manage our operating expenses. These changes reflect efforts to reshape the organization by streamlining our structure, particularly in operational and corporate functions, to better prioritize our go-to-market investments and focus our research and development investments on artificial intelligence ("AI") and driving innovation across our platform.

For the six months ended July 31, 2024, we incurred $12.6 million of expense associated with employee termination benefits in connection with these restructuring actions.

The following table shows the total amount incurred, and the liability, which is recorded in accrued compensation and employee benefits in the condensed consolidated balance sheets, for restructuring-related employee termination benefits as of July 31, 2024 (in thousands):


	Employee Termination Benefits
Accrued restructuring costs as of January 31, 2024(1)	$	335
Restructuring costs incurred during the six months ended July 31, 2024	12,612
Amount paid during the six months ended July 31, 2024	(2,762)
Accrued restructuring costs as of July 31, 2024	$	10,185
(1) Opening balance relates to our fiscal 2023 workforce restructuring actions, which were concluded during the second quarter of fiscal year 2024.

The following table shows the total restructuring costs incurred during the six months ended July 31, 2024 (in thousands):


	Employee Termination Benefits
Cost of subscription services revenue	$	318
Cost of professional services and other revenue	126
Sales and marketing	7,971
Research and development	1,681
General and administrative	2,516
Total	$	12,612

Defined Contribution Plans

We sponsor retirement plans for qualifying employees, including a 401(k) plan in the U.S. and defined contribution plans in certain other countries, to which we make matching contributions. Our total matching contributions to all defined contribution plans were $4.0 million and $3.5 million for the three months ended July 31, 2024 and 2023, respectively, and $10.2 million and $9.1 million for the six months ended July 31, 2024 and 2023, respectively.

Litigation

From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters which arise in the ordinary course of business. In accordance with ASC 450, Contingencies, we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.

UiPath and certain of its officers and directors are currently parties to the following litigation matters:

On September 6, 2023, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, then Co-CEO Daniel Dines, and Chief Financial Officer ("CFO") Ashim Gupta, captioned In re UiPath, Inc. Securities Litigation (the "2023 Securities Action"). The initial complaint asserted claims under Sections 10(b) and 20(a) of the Exchange Act, and alleged that defendants made material misstatements and omissions, including regarding UiPath’s competitive position and its financial results. On January

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

26, 2024, the lead plaintiff in the 2023 Securities Action filed an amended complaint, and on March 26, 2024, filed a further amended complaint, which alleges Securities Act claims under Sections 11 and 15 as well as Exchange Act claims under Section 10(b), Rule 10b-5, and Section 20(a). In support of the Securities Act claims, the plaintiff alleges material misstatements and omissions in UiPath’s April 2021 Registration Statement, including regarding UiPath’s competitive position and its financial results. The operative complaint is purportedly brought on behalf of a putative class of persons who purchased or otherwise acquired UiPath common stock between April 21, 2021 and September 27, 2022. It seeks unspecified monetary damages, costs and attorneys’ fees, and other unspecified relief as the Court deems appropriate. Defendants moved to dismiss the second amended complaint on April 23, 2024. The Court has not yet ruled on defendants' motion.

On November 30, 2023, a purported shareholder derivative lawsuit was filed in the United States District Court for the Eastern District of New York against UiPath, as nominal defendant, and then Co-CEO Daniel Dines, CFO Ashim Gupta, and several of UiPath’s current and former directors. The case is captioned Polilingua Limited v. Daniel Dines, et al. The lawsuit alleges that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements at issue in the 2023 Securities Action and by causing UiPath to repurchase shares at allegedly inflated prices. The plaintiff seeks unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys’ fees and certain changes to UiPath’s corporate governance and internal controls. Similar cases were filed in the District of Delaware and in the Southern District of New York (together with Polilingua Limited v. Daniel Dines, et al, the "Derivative Litigations"). The Derivative Litigations are at an early stage; in each case the matter has been stayed, pending the outcome of the Court's decision on the defendants' motion to dismiss the 2023 Securities Action.

On June 20, 2024, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, CEO Daniel Dines, former CEO Robert Enslin, and CFO Ashim Gupta. The case is captioned Steiner v. UiPath, et al (the "2024 Securities Action"). The complaint asserts claims under Sections 10(b) and 20(a) of the Exchange Act on behalf of a putative class of persons who purchased or acquired UiPath common stock between December 1, 2023 and May 29, 2024, and alleges that defendants made material misstatements and omissions, including regarding the Company's AI-powered Business Automation Platform and the Company's strategy for, the success of, and customer demand for the platform. The complaint seeks unspecified monetary damages, costs and attorneys' fees, and other unspecified relief as the Court deems appropriate. On August 6, 2024, a second putative class action was filed in the United States District Court for the Southern District of New York against UiPath, CEO Daniel Dines, former CEO Robert Enslin, and CFO Ashim Gupta. The case is captioned Brunozzi v. UiPath, et al. The allegations in the complaint are identical to those made in Steiner v. UiPath et al. except that the Brunozzi complaint defines the putative class to include purchasers of UiPath call options and sellers of put options. On August 19, 2024, two motions to appoint lead counsel and lead plaintiff and to consolidate the Steiner and Brunozzi actions were filed in the 2024 Securities Action. The Court has not yet ruled on these motions.

On July 8, 2024, a purported shareholder derivative lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, as nominal defendant, CEO Daniel Dines, former CEO Robert Enslin, CFO Ashim Gupta, and UiPath's board of directors. The case is captioned Gera v. UiPath, et al. The lawsuit alleges that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements made during the time period at issue in the 2024 Securities Action, and by allegedly causing UiPath to repurchase shares at allegedly inflated prices. The plaintiff seeks unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys' fees and certain changes to UiPath's corporate governance and internal controls. The matter has been stayed pending further action in the 2024 Securities Action.

We have not recorded any accrual related to the aforementioned litigation matters as of July 31, 2024, as we believe a loss in these matters is neither probable nor estimable at this time.

Warranty

We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made.

Other Matters

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Our indirect tax positions are subject to audit in multiple jurisdictions globally, with a key focus on our largest operational territories, including the U.S., Romania, India, and the U.K. Our Romanian subsidiary was subjected to audits by the Agenția Națională de Administrare Fiscală ("ANAF") for value-added tax and corporate income tax for the periods January 2020 through January 2022 and January 2018 through January 2022, respectively, which were completed during the three months ended April 30, 2024. With regard to the value-added tax audit, an assessment has been issued; we disagree with this assessment and are in the process of appealing. We have not recorded any reserves related to this audit as of July 31, 2024 as it is not probable that a material loss has been incurred. For additional information regarding the corporate income tax audit, refer to Note 12, Income Taxes.

Non-Cancelable Purchase Obligations

In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services, software products and services, and purchase of credits toward products and services from strategic alliance partners.

As of July 31, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):


	Amount
Remainder of year ending January 31, 2025	$	21,764
Year ending January 31,
2026	49,559
2027	25,807
2028	8,474
2029	17
Thereafter	1
Total	$	105,622

10. Stockholders’ Equity

Stock Repurchase Program

On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization was scheduled to expire on March 1, 2025.

During the three and six months ended July 31, 2024, we repurchased 16.3 million and 17.3 million shares of our Class A common stock at an average price of $12.05 and $12.67 per share (inclusive of brokerage commission), respectively. For the three and six months ended July 31, 2024, we accrued $0.7 million of related excise tax pursuant to the Inflation Reduction Act of 2022 which is included in the cost of treasury stock on our condensed consolidated balance sheet.

Subsequent to July 31, 2024, between August 1, 2024 and September 3, 2024, we repurchased an additional 10.7 million shares of our Class A common stock at an average price of $11.67 per share. On August 30, 2024, our board of directors authorized the repurchase of an additional $500.0 million of our Class A common stock. Refer to Note 14, Subsequent E vents for further information.

Charitable Donations of Class A Common Stock

We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. We contributed 0.3 million shares of our Class A common stock during each of the six-month periods ended July 31, 2024 and 2023 to a donor-advised fund in connection with our

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Pledge 1% commitment. The aggregate fair values of the shares on the respective contribution dates of $6.6 million and $4.2 million were recorded within general and administrative expense in the condensed consolidated statements of operations for the six months ended July 31, 2024 and 2023, respectively.

Accumulated Other Comprehensive Income

For the six months ended July 31, 2024 and 2023, changes in the components of accumulated other comprehensive income were as follows (in thousands):


	Foreign Currency Translation Adjustments		Unrealized Loss on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2024	$	8,925	$	(100)	$	8,825
Other comprehensive loss, net of tax	(691)		(29)		(720)
Balance as of July 31, 2024	$	8,234	$	(129)	$	8,105


	Foreign Currency Translation Adjustments		Unrealized Loss on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2023	$	8,231	$	(619)	$	7,612
Other comprehensive income (loss), net of tax	3,912		(18)		3,894
Balance as of July 31, 2023	$	12,143	$	(637)	$	11,506

11. Equity Incentive Plans and Stock-Based Compensation

2021 Stock Plan

In April 2021, prior to and in connection with our initial public offering ("IPO"), we adopted our 2021 Equity Incentive Plan (the "2021 Plan"), which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards ("RSAs"), restricted stock units ("RSUs"), performance stock units, and other forms of awards. As of July 31, 2024, we have reserved 202.2 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase.

2021 Employee Stock Purchase Plan

In April 2021, prior to and in connection with the IPO, we adopted our 2021 Employee Stock Purchase Plan (the “ESPP”). As of July 31, 2024, the ESPP authorizes the issuance of 27.2 million shares of our Class A common stock under purchase rights granted to our employees. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2) 15.5 million shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (a) 85% of the fair market value of our Class A common stock as of the commencement of the offering period, and (b) 85% of the fair market value of our Class A common stock on the corresponding purchase date.

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Stock Options

Stock option activity during the six months ended July 31, 2024 was as follows:


	Stock Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2024	11,080	$	3.49	7.8	$	216,010
Granted	1,876	$	0.10
Exercised	(2,153)	$	0.30
Forfeited	(888)	$	14.73
Outstanding as of July 31, 2024	9,915	$	2.53	7.8	$	99,333

Vested and exercisable as of July 31, 2024	4,630	$	5.31	6.6	$	35,540

The weighted-average grant date fair value of stock options granted during the six months ended July 31, 2024 was $20.47 per share. The intrinsic value of stock options exercised during the six months ended July 31, 2024 was $40.9 million.

Unrecognized compensation expense associated with unvested stock options granted and outstanding as of July 31, 2024 was approximately $101.7 million, which is to be recognized over a weighted-average remaining period of 2.1 years.

Restricted Stock Units

RSU activity during the six months ended July 31, 2024 was as follows:


	RSUs (in thousands)	Weighted-Average Grant Date Fair Value Per Share
Unvested as of January 31, 2024	31,272	$	19.89
Granted	12,094	$	19.79
Vested	(7,814)	$	21.38
Forfeited	(6,391)	$	18.97
Unvested as of July 31, 2024	29,161	$	19.65

The fair value of RSUs released during the six months ended July 31, 2024 was $138.5 million.

As of July 31, 2024, total unrecognized compensation expense related to unvested RSUs was approximately $531.5 million, which is to be recognized over a weighted-average remaining period of 2.2 years.

Employee Stock Purchase Plan Awards

During the six months ended July 31, 2024, 0.9 million shares were purchased under the ESPP at $10.21 per share. As of July 31, 2024, total unrecognized compensation expense related to the ESPP was approximately $2.4 million, which is to be recognized over a weighted-average remaining period of 0.4 years.

Stock-Based Compensation Associated with Business Acquisition

At the closing of the acquisition of Re:infer LTD on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) to be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

July 31, 2024, total unrecognized compensation expense related to these shares was $2.5 million, which is to be recognized over a weighted-average remaining period of 1.0 year.

Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Cost of subscription services revenue	$	5,284	$	3,809	$	9,560	$	6,987
Cost of professional services and other revenue	3,015		3,083		5,485		5,782
Sales and marketing	37,473		39,007		73,689		72,130
Research and development	32,654		33,071		61,796		57,844
General and administrative	15,879		23,127		32,502		44,402
Total	$	94,305	$	102,097	$	183,032	$	187,145

12. Income Taxes

Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences.

We had a provision for income taxes of $3.8 million, reflecting an effective tax rate of (4.7)%, and $3.8 million, reflecting an effective tax rate of (6.8)%, for the three months ended July 31, 2024 and 2023, respectively. For the three months ended July 31, 2024 and 2023, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets ("DTAs") for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries.

We had a provision for income taxes of $7.6 million, reflecting an effective tax rate of (7.1)%, and $7.5 million, reflecting an effective tax rate of (8.8)%, for the six months ended July 31, 2024 and 2023, respectively. For the six months ended July 31, 2024 and 2023, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing DTAs for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries.

The realization of tax benefits of net DTAs is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the six months ended July 31, 2024, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. will not be realized. Accordingly, we have recorded a full valuation allowance against U.S., Romania, and U.K. DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance.

As of July 31, 2024, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $0.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. Our tax positions are subject to income tax audits in multiple tax jurisdictions globally, with a currently open audit in India, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. Our Romanian subsidiary was subjected to a corporate income tax audit by ANAF for the period from January 2018 through January 2022, which was completed during the three months ended April 30, 2024. Certain deductions have been disallowed, resulting in a proposed reduction of net operating loss carryforwards of approximately $66.7 million. We are in the process of appealing this disallowance. In addition, we have engaged in two bilateral transfer pricing negotiations for our transfer pricing model, one between the U.S. and Romania, and one between Japan and Romania. These negotiations are still underway and the authorities are in the process of

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

determining the cost sharing allocations between the respective countries. At this time, we do not expect any significant changes in the next fiscal quarter based on the current positions undertaken by us.

In 2023, Romania adopted an alternative minimum tax that is applicable to all corporate taxpayers, including those reporting a net loss, for tax years commencing after January 1, 2024. As this tax is based on gross receipts, associated expense is included in operating expenses in our condensed consolidated statements of operations, and is not accounted for as income taxes.

13. Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands except per share amounts):


	Three Months Ended July 31,
	2024				2023
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(73,600)	$	(12,497)	$	(51,519)	$	(8,842)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted	485,589		82,453		480,430		82,453
Net loss per share, basic and diluted	$	(0.15)	$	(0.15)	$	(0.11)	$	(0.11)


	Six Months Ended July 31,
	2024				2023
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(98,192)	$	(16,641)	$	(78,688)	$	(13,574)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted	486,520		82,453		477,969		82,453
Net loss per share, basic and diluted	$	(0.20)	$	(0.20)	$	(0.16)	$	(0.16)

Table of Contents

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share were as follows (in thousands):


	Three Months Ended July 31,
	2024		2023
	Class A	Class B	Class A	Class B
Unvested RSUs	33,472	—	40,122	—
Outstanding stock options	10,582	—	14,206	—
Shares subject to repurchase from RSAs and early exercised stock options	16	—	53	—
Shares issuable under ESPP	833	—	680	—
Returnable shares issued in connection with business acquisition	269	—	422	—
Total	45,172	—	55,483	—


	Six Months Ended July 31,
	2024		2023
	Class A	Class B	Class A	Class B
Unvested RSUs	32,858	—	38,760	—
Outstanding stock options	10,762	—	14,047	—
Shares subject to repurchase from RSAs and early exercised stock options	22	—	58	—
Shares issuable under ESPP	762	—	787	—
Returnable shares issued in connection with business acquisition	272	—	425	—
Total	44,676	—	54,077	—

14. Subsequent Events

On August 30, 2024, our board of directors authorized an additional $500.0 million of repurchases of our outstanding shares of Class A common stock under the stock repurchase program. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. The current authorization may be suspended or discontinued at any time and does not have a specified expiration date.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements and the related notes and the discussion under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for the fiscal year ended January 31, 2024 included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 27, 2024 (the "2024 Form 10-K"). This discussion, particularly information with respect to our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, includes forward-looking statements that involve risks and uncertainties as described under the heading “Special Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q. You should review the disclosure under the heading "Risk Factors" in this Quarterly Report on Form 10-Q and under Part I, Item 1A, "Risk Factors," in the 2024 Form 10-K for discussion of important factors that could cause our actual results to differ materially from those anticipated in these forward-looking statements.

Overview

First established in a Bucharest, Romania apartment in 2005, UiPath was incorporated in Delaware in 2015 as a company principally focused on building and managing automations and developing computer vision technology, which remains the foundation of our platform today. Since that time, we have evolved from our beginnings in robotic process automation ("RPA") into an end-to-end AI-powered Business Automation Platform through development and acquisitions, have launched new products, and have expanded our operations across the globe. Our vision is to enable automation across all knowledge work to accelerate human achievement.

The UiPath Business Automation Platform is The Foundation of Innovation™. We provide our customers with a robust set of capabilities that allow them to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale. Our platform enables customers to integrate AI with automation, enabling automation to take action based on learning and experience. It enables employees to quickly build automations for both existing and new processes and to automate a vast array of actions including, but not limited to, logging into applications, extracting information from documents, moving folders, filling in forms, reading emails, and updating information fields and databases. The ability of our platform to replicate steps performed by humans in executing business processes drives operational efficiencies and enables companies to deliver on key digital initiatives with greater speed, agility, and accuracy.

AI-powered automation is here, and its momentum is continuing to grow as organizations around the world begin to understand the combined power of automation and AI to drive efficiency and business outcomes. We aspire to be the defining business automation platform, advancing the evolution of automation and AI as a way of working and a catalyst for continuous reinvention.

Table of Contents

Business Highlights for the Three and Six Months Ended July 31, 2024:

•Quarter-to-date revenue of $316.3 million increased 10% year-over-year.

•Year-to-date revenue of $651.4 million increase 13% year-over-year.

•ARR at July 31, 2024 of $1,550.6 million increased 19% year-over-year.

•Gross margin was 80% for the three months ended July 31, 2024, compared to 83% for the three months ended July 31, 2023.

•Gross margin was 82% for the six months ended July 31, 2024, compared to 84% for the six months ended July 31, 2023.

•Cash flow from operations was $146.4 million for the six months ended July 31, 2024, compared to $111.6 million for the six months ended July 31, 2023.

•Cash and cash equivalents, restricted cash, and marketable securities were $1,743.8 million as of July 31, 2024, compared to $1,880.3 million as of January 31, 2024.

Table of Contents

Macroeconomic Environment

As a corporation with a global presence, we are subject to risks and uncertainties caused by significant events with macroeconomic impacts, including, but not limited to, the impact of changes in geopolitical relationships, fluctuating inflation and interest rates, monetary policy changes, and foreign currency fluctuations. Additionally, these macroeconomic impacts have generally disrupted the operations of our customers, prospective customers, and partners.

Internationally, we price our platform in currencies that may not be the functional currency. Accordingly, the heightened volatility of global markets has exposed us and will continue to expose us to foreign currency fluctuations, which may impact demand for our platform, our near-term results, the comparability of results to prior periods, and our ability to predict future results.

Further, cash, cash equivalents, and marketable securities represent a significant portion of our total assets, and the return on our cash, cash equivalents, and marketable securities is sensitive to changes in interest rates. Volatility in the interest rate environment may impact the amount of interest and other income reported on our condensed consolidated statements of operations, the comparability of these amounts to prior periods, and our ability to predict future profitability.

We continuously monitor the direct and indirect impacts of these circumstances on our business and financial results, as well as the overall global economy and geopolitical landscape.

Table of Contents

Fiscal Year 2025 Restructuring Actions

On July 8, 2024, our board of directors approved restructuring actions to manage our operating expenses. These changes reflect efforts to reshape the organization by streamlining our structure, particularly in operational and corporate functions, better prioritizing our go-to-market investments and focusing our research and development investments on artificial intelligence and driving innovation across our platform. Refer to Note 9 , Commitments and Contingencies—Workforce Restructuring included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information.

Table of Contents

Key Performance Metric

We monitor annualized renewal run-rate ("ARR") to help us measure and evaluate the effectiveness of our operations.

ARR is the key performance metric we use in managing our business because it illustrates our ability to acquire new subscription customers and to maintain and expand our relationships with existing subscription customers. We define ARR as annualized invoiced amounts per solution SKU from subscription licenses and maintenance and support obligations assuming no increases or reductions in customers' subscriptions. ARR does not include the costs we may incur to obtain such subscription licenses or provide such maintenance and support, and does not reflect any actual or anticipated reductions in invoiced value due to contract non-renewals or service cancellations other than for certain reserves, for example those for credit losses or disputed amounts. At July 31, 2024 and 2023, our ARR was $1,550.6 million and $1,307.9 million, respectively, representing a growth rate of 19%. Approximately 17% of this growth was due to new customers and 83% to existing customers. Our dollar-based net retention rate, which represents the net expansion of ARR from existing customers over the preceding 12 months, was 115% and 121% as of July 31, 2024 and 2023, respectively. We calculate dollar-based net retention rate as of a period end by starting with the ARR from the cohort of all customers as of 12 months prior to such period end ("Prior Period ARR"). We then calculate the ARR from these same customers as of the current period end ("Current Period ARR"). Current Period ARR includes any expansion and is net of contraction or attrition over the last 12 months, but does not include ARR from new customers in the current period. We then divide the total Current Period ARR by the total Prior Period ARR to arrive at the point-in-time dollar-based net retention rate.

Our ARR may fluctuate as a result of a number of factors, including customers’ satisfaction or dissatisfaction with our platform, pricing, competitive offerings, economic conditions, overall changes in our customers’ spending levels, and our ability to successfully execute on our strategic goals. ARR should be viewed independently of revenue and deferred revenue as ARR is an operating metric and is not intended to be combined with or to replace these items. For clarity, we use annualized invoiced amounts per solution SKU rather than revenue calculated in accordance with U.S. GAAP to calculate our ARR. Our invoiced amounts are not matched to transfer of control of the performance obligations associated with the underlying subscription licenses and maintenance and support obligations. This can result in timing differences between our GAAP revenue and ARR calculations. Generally speaking, our ARR calculation simply takes our invoiced amounts per solution SKU under a subscription license or maintenance agreement and divides that amount by the invoice term and multiplies by 365 days to derive the annualized value. In contrast, for our revenue calculated in accordance with GAAP, subscription licenses revenue derived from the sale of term-based licenses hosted on-premises is recognized at the point in time when the customer is able to use and benefit from our software, which is generally upon delivery to the customer or upon the commencement of the renewal term, and maintenance, support, and software-as-a-service ("SaaS") revenue is recognized ratably over the term of the arrangement. ARR is not a forecast of future revenue. Unlike ARR, revenue is impacted by contract start and end dates and duration. The timing of recognition of ARR is determined by contract billing structure, whereas billing structure will neither accelerate nor delay recognition of future revenue. For example, in a multi-year contract invoiced upfront, ARR is the annualized invoiced amount per solution SKU related to the final year of the contract assuming no reserve is applied, whereas revenue is determined by total contract value and timing of satisfaction of the underlying performance obligations. ARR does not include invoiced amounts associated with perpetual licenses or professional services. Investors should not place undue reliance on ARR as an indicator of our future or expected results. Moreover, our presentation of ARR may differ from similarly titled metrics presented by other companies and may not be comparable to such other metrics.

Table of Contents

A summary of ARR-related data at July 31, 2024 and 2023 is as follows:


	At July 31,
	2024			2023
	(dollars in thousands)
ARR	$	1,550,605		$	1,307,904
Incremental ARR (1)	242,701			264,618

Customers with ARR ≥ $1 million:
Number of customers	293			254
Percent of current period revenue	43		%	43		%
Customers with ARR ≥ $100 thousand:
Number of customers	2,163			1,930
Percent of current period revenue	83		%	81		%

Dollar-based net retention rate	115		%	121		%
(1) For the twelve months ended July 31, 2024 and 2023, respectively

Components of Results of Operations

Revenue

We derive revenue from the sale of: (1) software licenses for use of our proprietary software and related maintenance and support; (2) the right to access certain software products we host (i.e., SaaS); and (3) professional services.

We have a unified commercial offering for software products with both on-premise and cloud deployment options that allows customers the choice of either deployment option throughout the term of the contract. These Flex Offerings are comprised of three types of performance obligations: term license, maintenance and support, and SaaS.

Licenses

Our term licenses (typically sold as a portion of Flex Offerings) provide customers the right to use software for a specified period of time. Revenue for licenses is recognized at the point in time at which the customer is able to use and benefit from the software, which is generally upon delivery to the customer or upon commencement of the renewal term. As licenses revenue is recognized at a point in time, any shift in contract start dates and duration, for example due to lengthening sales cycles and increased deal scrutiny, will have a direct impact on our licenses revenue.

Subscription Services

We generate subscription services revenue through the provision of: (1) maintenance and support services, which include technical support and unspecified updates and upgrades on a when-and-if-available basis for our licenses, and (2) SaaS products (typically sold as a portion of Flex Offerings). Maintenance and support and SaaS products represent stand-ready obligations for which revenue is recognized ratably over the term of the arrangements.

Professional Services and Other

Professional services and other revenue consists of fees associated with professional services for process automation, customer education, and training services. Our professional services contracts are structured on a time and materials or fixed price basis, and the related revenue is recognized as the services are rendered.

Cost of Revenue

Licenses

Cost of licenses revenue consists of all direct costs to deliver our licenses to customers, amortization of software development costs related to our licenses, and amortization of acquired developed technology.

Table of Contents

Subscription Services

Cost of subscription services revenue primarily consists of personnel-related expenses of our customer support and technical support teams, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of subscription services revenue also includes third-party consulting services, hosting costs related to our SaaS products, amortization of acquired developed technology and capitalized software development costs related to SaaS products, depreciation, and allocated overhead. Overhead is allocated based on applicable headcount. We recognize these expenses as they are incurred. We expect cost of subscription services revenue to continue to increase in absolute dollars for the foreseeable future as our SaaS business grows. In the future, we expect further expansion of our cloud-based deployments. As more of our customer base deploys our products via SaaS, we expect our gross margin to be impacted by increased hosting fees and cloud infrastructure costs.

Professional Services and Other

Cost of professional services and other revenue primarily consists of personnel-related expenses of our professional services team, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of professional services and other revenue also includes expenses related to subcontracted third-party services, depreciation, and allocated overhead. We recognize these expenses as they are incurred. We expect cost of professional services and other revenue to increase in absolute dollars for the foreseeable future.

Operating Expenses

Our operating expenses consist of sales and marketing, research and development, and general and administrative expenses. Personnel-related expenses are the most significant component of operating expenses and consist of salaries and bonuses, stock-based compensation expense, and employee benefit costs. Operating expenses also include allocated overhead.

Sales and Marketing

Sales and marketing expenses consist primarily of personnel-related expenses associated with our sales and marketing teams and related sales support teams, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Sales and marketing expenses also include sales and partner commissions, marketing event costs, advertising costs, travel, trade shows, other marketing materials, and allocated overhead. We expect that over the longer term our sales and marketing expenses will decrease as a percentage of revenue, although this percentage may fluctuate from period to period due to timing and extent of expenses.

Research and Development

Research and development expenses consist primarily of personnel-related expenses, including salaries and bonuses, stock-based compensation expense, and employee benefits costs, for our research and development employees, and allocated overhead. Research and development costs are expensed as incurred, with the exception of certain software development costs which are eligible for capitalization. We expect that our research and development expenses will increase in absolute dollars for the foreseeable future as we continue to invest in efforts to develop new technology and enhance the functionality and capabilities of our existing products and platform infrastructure. Our research and development expenses may fluctuate as a percentage of revenue from period to period due to the timing and extent of expenses.

General and Administrative

General and administrative expenses consist primarily of personnel-related expenses, including salaries and bonuses, stock-based compensation expense, and employee benefits costs, associated with our finance, legal, human resources, compliance, and other administrative teams, as well as accounting and legal professional services fees, other corporate-related expenses, and allocated overhead. We expect that over the longer term our general and administrative expenses will decrease as a percentage of revenue, although this percentage may fluctuate from period to period due to timing and extent of expenses.

Interest Income

Interest income consists of interest earned on our cash and cash equivalents and marketable securities.

Table of Contents

Other Income, Net

Other income, net primarily consists of foreign exchange gains and losses. Other income, net also includes amortization of discounts and premiums on marketable securities.

Provision For Income Taxes

Provision for income taxes consists of U.S. federal and state income taxes and income taxes in foreign jurisdictions in which we conduct business. We currently maintain a full valuation allowance on our U.S. federal and state, Romanian, and U.K. DTAs, as we have concluded that it is more likely than not that these DTAs will not be realized. Our effective tax rate is affected by tax rates in foreign jurisdictions and the relative amounts of income we earn in those jurisdictions, as well as by non-deductible expenses as permanent differences, and by changes in our valuation allowances.

Table of Contents

Results of Operations

The following tables set forth selected condensed consolidated statement of operations data and such data as a percentage of total revenue for each of the periods indicated:


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
	(in thousands)				(in thousands)
Revenue:
Licenses	$	112,251	$	119,300	$	252,379	$	253,339
Subscription services	194,673		159,999		379,804		306,351
Professional services and other	9,329		8,011		19,182		17,208
Total revenue	316,253		287,310		651,365		576,898
Cost of revenue:
Licenses (1)	2,393		3,008		4,994		5,555
Subscription services (1)(2)(3)(4)	43,529		26,777		80,283		49,855
Professional services and other (2)(3)(4)	17,398		19,202		33,368		37,244
Total cost of revenue	63,320		48,987		118,645		92,654
Gross profit	252,933		238,323		532,720		484,244
Operating expenses:
Sales and marketing (1)(2)(3)(4)	194,330		169,725		374,469		330,131
Research and development (2)(3)(4)	98,433		86,606		184,036		161,948
General and administrative (1)(2)(3)(4)	63,519		59,577		127,029		116,161
Total operating expenses	356,282		315,908		685,534		608,240
Operating loss	(103,349)		(77,585)		(152,814)		(123,996)
Interest income	13,370		13,582		27,200		27,430
Other income, net	7,710		7,472		18,389		11,766
Loss before income taxes	(82,269)		(56,531)		(107,225)		(84,800)
Provision for income taxes	3,828		3,830		7,608		7,462
Net loss	$	(86,097)	$	(60,361)	$	(114,833)	$	(92,262)

(1) Includes amortization of acquired intangible assets as follows:
Cost of licenses revenue	$	819	$	851	$	1,663	$	1,687
Cost of subscription services revenue	595		594		1,188		1,178
Sales and marketing	298		681		850		1,352
General and administrative	39		41		78		82
Total amortization of acquired intangible assets	$	1,751	$	2,167	$	3,779	$	4,299

(2) Includes stock-based compensation expense as follows:
Cost of subscription services revenue	$	5,284	$	3,809	$	9,560	$	6,987
Cost of professional services and other revenue	3,015		3,083		5,485		5,782
Sales and marketing	37,473		39,007		73,689		72,130
Research and development	32,654		33,071		61,796		57,844
General and administrative	15,879		23,127		32,502		44,402
Total stock-based compensation expense	$	94,305	$	102,097	$	183,032	$	187,145

(3) Includes employer payroll tax expense related to equity transactions as follows:
Cost of subscription services revenue	$	68	$	85	$	245	$	175
Cost of professional services and other revenue	27		68		93		139
Sales and marketing	577		501		1,800		1,725
Research and development	288		584		918		1,185
General and administrative	175		491		590		869
Total employer payroll tax expense related to equity transactions	$	1,135	$	1,729	$	3,646	$	4,093

(4) Includes restructuring expense as follows:
Cost of subscription services revenue	$	318	$	167	$	318	$	167
Cost of professional services and other revenue	126		—		126		—
Sales and marketing	7,971		1,087		7,971		$	1,316
Research and development	1,681		109		1,681		394
General and administrative	2,516		354		2,516		729
Total restructuring expense	$	12,612	$	1,717	$	12,612	$	2,606

Table of Contents


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
	(as a percentage of revenue)				(as a percentage of revenue)
Revenue:
Licenses	35	%	41	%	39	%	44	%
Subscription services	62	%	56	%	58	%	53	%
Professional services and other	3	%	3	%	3	%	3	%
Total revenue	100	%	100	%	100	%	100	%
Cost of revenue:
Licenses	1	%	1	%	1	%	1	%
Subscription services	14	%	9	%	12	%	9	%
Professional services and other	5	%	7	%	5	%	6	%
Total cost of revenue	20	%	17	%	18	%	16	%
Gross profit	80	%	83	%	82	%	84	%
Operating expenses:
Sales and marketing	62	%	59	%	57	%	57	%
Research and development	31	%	30	%	28	%	28	%
General and administrative	20	%	21	%	20	%	20	%
Total operating expenses	113	%	110	%	105	%	105	%
Operating loss	(33)	%	(27)	%	(23)	%	(21)	%
Interest income	4	%	4	%	4	%	4	%
Other income, net	3	%	3	%	3	%	2	%
Loss before income taxes	(26)	%	(20)	%	(16)	%	(15)	%
Provision for income taxes	1	%	1	%	1	%	1	%
Net loss	(27)	%	(21)	%	(17)	%	(16)	%

Table of Contents

Comparison of the Three Months Ended July 31, 2024 and 2023

Revenue


	Three Months Ended July 31,
	2024		2023		Change		Change %
	(dollars in thousands)
Licenses	$	112,251	$	119,300	$	(7,049)	(6)	%
Subscription services	194,673		159,999		34,674		22	%
Professional services and other	9,329		8,011		1,318		16	%
Total revenue	$	316,253	$	287,310	$	28,943	10	%

Total revenue increased by $28.9 million, or 10%, for the three months ended July 31, 2024 compared to the three months ended July 31, 2023, due to a $34.7 million increase in subscription services revenue and a $1.3 million increase in professional services and other revenue, partially offset by a $7.0 million decrease in licenses revenue related in part to the transition to our Flex Offerings. As we continued to expand our sales efforts in the U.S. and internationally, total revenue grew across all regions. Of the growth in total revenue, 37% was attributable to new customers and 63% was attributable to existing customers. Subscription services revenue is recognized ratably over the subscription term; therefore, the increase in subscription services revenue is driven both by sales in prior periods for which we continue to provide maintenance and support and SaaS and by new sales in the current period.

Cost of Revenue and Gross Margin


	Three Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Licenses	$	2,393		$	3,008		$	(615)	(20)	%
Subscription services	43,529			26,777			16,752		63	%
Professional services and other	17,398			19,202			(1,804)		(9)	%
Total cost of revenue	$	63,320		$	48,987		$	14,333	29	%
Gross margin	80		%	83		%

Total cost of revenue increased by $14.3 million, or 29%, for the three months ended July 31, 2024 compared to the three months ended July 31, 2023, primarily due to a $16.8 million increase in cost of subscription services revenue. The increase in cost of subscription services revenue was primarily driven by a $6.5 million increase in personnel-related expenses, which included a $4.3 million increase in salary-related and bonus expenses associated with both increased headcount and merit increases, a $1.5 million increase in stock-based compensation expense, and a $0.9 million aggregate increase in employee insurance costs and employer payroll taxes. Cost of subscription services revenue was also impacted by a $6.3 million increase in hosting and software services costs as a result of increased usage, and a $2.8 million increase in costs associated with the use of third-party vendors.

Our gross margin decreased to 80% for the three months ended July 31, 2024 compared to 83% for the three months ended July 31, 2023 due to the aforementioned increase in cost of subscription services revenue driven by increased personnel and hosting costs.

Operating Expenses

Sales and Marketing


	Three Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Sales and marketing	$	194,330		$	169,725		$	24,605	14	%
Percentage of revenue	62		%	59		%

Sales and marketing expense increased by $24.6 million, or 14%, for the three months ended July 31, 2024 compared to the three months ended July 31, 2023. The increase was primarily attributable to a $16.8 million increase in personnel-related expenses, which included a $6.9 million increase in employee termination benefits

Table of Contents

related to our fiscal year 2025 restructuring actions, a $6.8 million increase in salary-related and bonus expenses associated with both increased headcount and merit increases, a $2.4 million increase in general employee severance, a $1.3 million increase in employee insurance and other employee benefits costs, and a $1.0 million increase in employer payroll taxes, partially offset by a $1.5 million decrease in stock-based compensation expense. Sales and marketing expense was also impacted by a $7.4 million increase in sales commissions expense as a result of higher amortization of capitalized contract acquisition costs and a $0.9 million increase in travel expenses mainly related to marketing events.

Research and Development


	Three Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Research and development	$	98,433		$	86,606		$	11,827	14	%
Percentage of revenue	31		%	30		%

Research and development expense increased by $11.8 million, or 14%, for the three months ended July 31, 2024 compared to the three months ended July 31, 2023. The increase was primarily attributable to a $5.7 million increase in hosting and software services costs. Research and development expense was also impacted by a $5.5 million increase in personnel-related expenses, which included a $4.3 million increase in salary-related and bonus expenses associated with both increased headcount and merit increases and a $1.6 million increase in employee termination benefits related to our fiscal year 2025 restructuring actions, partially offset by a $0.4 million decrease in stock-based compensation expense.

General and Administrative


	Three Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
General and administrative	$	63,519		$	59,577		$	3,942	7	%
Percentage of revenue	20		%	21		%

General and administrative expense increased by $3.9 million, or 7%, for the three months ended July 31, 2024 compared to the three months ended July 31, 2023. The increase was primarily attributable to a $3.0 million increase in software service expenses, a $2.9 million increase in third-party consulting fees, and a $2.4 million increase in other taxes. These increases were partially offset by a $4.1 million decrease in personnel-related expenses, which included a $7.2 million decrease in stock-based compensation, partially offset by a $2.3 million increase in employee termination benefits related to our fiscal year 2025 restructuring actions.

Interest Income


	Three Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Interest income	$	13,370		$	13,582		$	(212)	(2)	%
Percentage of revenue	4		%	4		%

Interest income remained relatively constant for the three months ended July 31, 2024 compared to the three months ended July 31, 2023.

Other Income, Net


	Three Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Other income, net	$	7,710		$	7,472		$	238	3	%
Percentage of revenue	3		%	3		%

Table of Contents

Other income, net remained relatively constant for the three months ended July 31, 2024 compared to the three months ended July 31, 2023.

Provision For Income Taxes


	Three Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Provision for income taxes	$	3,828		$	3,830		$	(2)	—	%
Percentage of revenue	1		%	1		%

Provision for income taxes remained relatively constant for the three months ended July 31, 2024 compared to the three months ended July 31, 2023.

Comparison of the Six Months Ended July 31, 2024 and July 31, 2023

Revenue


	Six Months Ended July 31,
	2024		2023		Change		Change %
	(dollars in thousands)
Licenses	$	252,379	$	253,339	$	(960)	—	%
Subscription services	379,804		306,351		73,453		24	%
Professional services and other	19,182		17,208		1,974		11	%
Total revenue	$	651,365	$	576,898	$	74,467	13	%

Total revenue increased by $74.5 million, or 13%, for the six months ended July 31, 2024 compared to the six months ended July 31, 2023, primarily due to a $73.5 million increase in subscription services revenue, related in part to the transition to our Flex Offerings. As we continued to expand our sales efforts in the U.S. and internationally, our revenue increased across all regions. Of the growth in total revenue, 27% was attributable to new customers and 73% was attributable to existing customers. Of the growth in total revenue attributable to existing customers, $8.0 million resulted from contract modifications wherein the revenue recognized originated from our existing balance of remaining performance obligations. Subscription services revenue is recognized ratably over the subscription term; therefore, the increase in subscription services revenue is driven by both sales in prior periods for which we continue to provide maintenance and support and SaaS, and by new sales in the current period.

Cost of Revenue and Gross Margin


	Six Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Licenses	$	4,994		$	5,555		$	(561)	(10)	%
Subscription services	80,283			49,855			30,428		61	%
Professional services and other	33,368			37,244			(3,876)		(10)	%
Total cost of revenue	$	118,645		$	92,654		$	25,991	28	%
Gross margin	82		%	84		%

Total cost of revenue increased by $26.0 million, or 28%, for the six months ended July 31, 2024 compared to the six months ended July 31, 2023, primarily due to a $30.4 million increase in cost of subscription services revenue, partially offset by a $3.9 million decrease in cost of professional services revenue. The increase in cost of subscription services revenue was primarily driven by a $12.8 million increase in personnel-related expenses, which included an $8.8 million increase in salary-related and bonus expenses associated with both increased headcount and merit increases, a $2.6 million increase in stock-based compensation expense, and a $1.9 million aggregate increase in employee insurance costs and employer payroll taxes. Cost of subscription services revenue was also impacted by an $11.1 million increase in hosting and software services costs as a result of increased usage and a $5.1 million increase in costs associated with the use of third-party vendors. The decrease in cost of professional services and other revenue was primarily driven by a $3.3 million decrease in personnel-related expenses, which

Table of Contents

included a $2.1 million decrease in salary-related and bonus expenses, a $0.3 million decrease in stock-based compensation expense, and a $0.5 million aggregate decrease in employee insurance costs and employer payroll taxes. Cost of professional services and other revenue was also impacted by a $0.6 million decrease in costs associated with the use of third-party subcontractors to deliver professional services to our customers.

Our gross margin decreased to 82% for the six months ended July 31, 2024 compared to 84% for the six months ended July 31, 2023 due to decrease in the proportion of higher-margin licenses revenue and increase in cost of subscription services revenue driven by increased personnel and hosting costs.

Operating Expenses

Sales and Marketing


	Six Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Sales and marketing	$	374,469		$	330,131		$	44,338	13	%
Percentage of revenue	57		%	57		%

Sales and marketing expense increased by $44.3 million, or 13%, for the six months ended July 31, 2024 compared to the six months ended July 31, 2023. This increase was primarily attributable to a $29.5 million increase in personnel-related expenses, which included a $16.1 million increase in salary-related and bonus expenses as a result of both increased headcount and merit increases, a $6.7 million increase in employee termination benefits related to our fiscal year 2025 restructuring actions, a $2.1 million increase in payroll taxes, a $1.6 million increase in stock-based compensation expense, and a $1.5 million increase in general employee severance. Sales and marketing expense was also impacted by a $12.6 million increase in sales commission expenses as a result of higher amortization of capitalized contract acquisition costs and a $3.8 million aggregate increase in marketing and travel-related expenses mainly related to marketing events. These increases were partially offset by a $1.3 million decrease in depreciation and amortization expense.

Research and Development


	Six Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Research and development	$	184,036		$	161,948		$	22,088	14	%
Percentage of revenue	28		%	28		%

Research and development expense increased by $22.1 million, or 14%, for the six months ended July 31, 2024 compared to the six months ended July 31, 2023. The increase was primarily attributable to an $11.1 million increase in third-party software services and hosting costs as a result of increased usage. Research and development expense was also impacted by a $10.2 million increase in personnel-related expenses, which included a $4.5 million increase in salary-related expenses associated with both increased headcount and merit increases, a $4.0 million increase in stock-based compensation expense, a $1.3 million increase in employee termination benefits related to our fiscal year 2025 restructuring actions, and a $0.5 million increase in general employee severance.

General and Administrative


	Six Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
General and administrative	$	127,029		$	116,161		$	10,868	9	%
Percentage of revenue	20		%	20		%

General and administrative expense increased by $10.9 million, or 9%, for the six months ended July 31, 2024 compared to the six months ended July 31, 2023. This increase was primarily attributable to an $8.0 million increase in software service expenses, a $3.3 million increase in other taxes, a $3.2 million increase in third-party consulting fees, a $2.4 million increase due to a credit loss recovery recorded in the prior comparable period, a $2.3 million

Table of Contents

increase in charitable donations mainly driven by the increased fair value of our Class A common shares contributed to a donor-advised fund in the current year. These increases were partially offset by a $7.1 million decrease in personnel-related expenses, which included an $11.9 million decrease in stock-based compensation expense partially offset by a $2.1 million increase in employee insurance costs and a $1.8 million increase in employee termination benefits related to our fiscal year 2025 restructuring actions, as well as a $2.3 million decrease in commercial insurance costs.

Interest Income


	Six Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Interest income	$	27,200		$	27,430		$	(230)	(1)	%
Percentage of revenue	4		%	4		%

Interest income remained relatively constant for the six months ended July 31, 2024 compared to the six months ended July 31, 2023.

Other Income, Net


	Six Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Other income, net	$	18,389		$	11,766		$	6,623	56	%
Percentage of revenue	3		%	2		%

Other income, net increased by $6.6 million, or 56%, for the six months ended July 31, 2024 compared to the six months ended July 31, 2023, primarily due to a $6.5 million net increase in amortization on marketable securities and cash equivalents and a $3.3 million increase in gains from foreign currency transactions, partially offset by $2.1 million of legal expense related to shareholder litigation and a $1.1 million decrease in sublease income.

Provision For Income Taxes


	Six Months Ended July 31,
	2024			2023			Change		Change %
	(dollars in thousands)
Provision for income taxes	$	7,608		$	7,462		$	146	2	%
Percentage of revenue	1		%	1		%

Provision for income taxes and effective tax rate remained relatively constant for the six months ended July 31, 2024 compared to the six months ended July 31, 2023.

Liquidity and Capital Resources

We have financed operations since our inception primarily through customer payments and net proceeds from sales of equity securities. Our principal uses of cash in recent periods have been to fund our operations, invest in capital expenditures, engage in various business acquisitions, and, more recently, repurchase shares of our Class A common stock. As of July 31, 2024, our principal sources of liquidity were cash, cash equivalents, and marketable securities totaling $1,743.4 million, and we had an accumulated deficit of $2,029.0 million. During the six months ended July 31, 2024, we reported a net loss of $114.8 million and net cash provided by operating activities of $146.4 million.

Our future capital requirements will depend on many factors, including our revenue growth rate, sales of our products and services, license renewal activity, the timing and the amount of cash received from customers, the expansion of sales and marketing activities, the timing and extent of spending to support development efforts, the introduction of new and enhanced products, the continuing market adoption of our products, expenses associated with international expansion, the timing and extent of capital expenditures to invest in existing and new office spaces, and the timing and extent of stock repurchases. We may in the future enter into arrangements to acquire or invest in complementary businesses, products, and technologies. We may be required to seek additional equity or

Table of Contents

debt financing. In the event that we require additional financing, we may not be able to raise such financing on terms acceptable to us or at all. If we are unable to raise additional capital or generate cash flows necessary to expand our operations and invest in continued innovation, we may not be able to compete successfully, which would harm our business, operations, and financial condition.

We believe that our existing cash and cash equivalents, marketable securities, and payments from customers will be sufficient to fund our anticipated cash requirements for the next twelve months and the long term.

Stock Repurchase Program

On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Refer to Note 10, Stockholders' Equity—Stock Repurchase Program for further details. On August 30, 2024 our board of directors authorized the repurchase of an additional $500.0 million of our Class A common stock. Refer to Note 1 4 , Subsequent Events for further details.

Cash Flows

The following table summarizes our cash flows for the periods presented:


	Six Months Ended July 31,
	2024		2023
	(in thousands)
Net cash provided by operating activities (1)	$	146,413	$	111,626
Net cash used in investing activities	$	(5,893)	$	(370,677)
Net cash used in financing activities	$	(260,887)	$	(45,827)

(1) Inclusive of:
Cash paid for employer payroll taxes related to employee equity transactions	$	(3,267)	$	(4,830)
Net receipts (payments) of employee tax withholdings on stock option exercises	$	9	$	(924)
Cash paid for restructuring costs	$	(2,762)	$	(4,792)

Operating Activities

Our largest source of operating cash is cash generation from sales to our customers. Our primary uses of cash from operating activities are for personnel-related expenses, direct costs to deliver licenses and provide subscription and professional services, and marketing expenses.

Net cash provided by operating activities for the six months ended July 31, 2024 of $146.4 million was driven by cash collections from our customers, which were approximately 12% higher than during the six months ended July 31, 2023. These cash inflows were partially offset by cash payments for operating expenditures, primarily associated with the compensation of our teams, including fiscal year 2024 annual bonuses paid in the first quarter of fiscal year 2025. Other cash operating expenditures included payments for professional services, software, and office rent.

Net cash provided by operating activities for the six months ended July 31, 2023 of $111.6 million was driven by cash collections from our customers, partially offset by cash payments for operating expenditures, primarily associated with the compensation of our teams, including annual bonuses paid in the first quarter of fiscal year 2024. Other cash operating expenditures included payments related to our fiscal 2023 workforce restructuring, which was concluded during the second quarter of fiscal year 2024, and payments for professional services, software, and office rent.

Investing Activities

Net cash used in investing activities for the six months ended July 31, 2024 of $5.9 million was primarily driven by $697.8 million in purchases of marketable securities and a $35.8 million investment in the H company, partially offset by $730.3 million in maturities of marketable securities.

Net cash used in investing activities for the six months ended July 31, 2023 of $370.7 million was primarily driven by $709.2 million in purchases of marketable securities and $2.9 million in capital expenditures, partially offset by $338.6 million in maturities of marketable securities.

Table of Contents

Financing Activities

Net cash used in financing activities for the six months ended July 31, 2024 of $260.9 million was primarily driven by $218.8 million in repurchases of Class A common stock under our stock repurchase program, $45.9 million in payments of tax withholdings on net settlement of equity awards, and $5.6 million in deferred cash consideration paid on the second anniversary of the acquisition of Re:infer LTD, partially offset by $8.6 million in proceeds from ESPP contributions.

Net cash used in financing activities for the six months ended July 31, 2023 of $45.8 million was driven by $52.8 million in payments of tax withholdings on the net settlement of equity awards, $5.9 million in deferred cash consideration paid on the first anniversary of the acquisition of Re:infer LTD, and $0.7 million in net payments of tax withholdings on sell-to-cover equity award transactions, partially offset by $9.6 million in proceeds from ESPP contributions and $3.9 million in proceeds from the exercise of stock options.

Material Cash Requirements

Our material cash requirements predominantly relate to working capital requirements, including employee compensation, payment of employee tax withholdings on net settlement of equity awards, and employee termination benefits related to our fiscal year 2025 restructuring actions, and material contractual obligations, including leases and purchase commitments.

As of July 31, 2024, accrued compensation and benefits of $77.4 million are included in current liabilities on our condensed consolidated balance sheet. Refer to Note 8, Consolidated Balance Sheet Components—Accrued Expenses and Other Current Liabilities for details of additional short-term payroll-related obligations included in accrued expenses and other current liabilities.

Refer to Note 7, Operating Leases for more detailed information regarding timing of future lease payments, and Note 9, Commitments and Contingencies—Non-Cancelable Purchase Obligations for more detailed information regarding timing of purchase commitments. There were no significant changes during the six months ended July 31, 2024 from the contractual obligations disclosed in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” set forth in the 2024 Form 10-K.

Our stock repurchase program may also represent a material use of cash depending upon the number of shares repurchased, which is ultimately discretionary. Refer to Note 10, Stockholders' Equity—Stock Repurchase Program for further details.

Critical Accounting Estimates

There have been no material changes to our critical accounting estimates as compared to those disclosed in the 2024 Form 10-K.

Recent Accounting Pronouncements

See Note 2, Summary of Significant Accounting Policies—Recently Issued Accounting Pronouncements, included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is principally the result of fluctuations in interest rates and foreign currency exchange rates.

Interest Rate Risk

As of July 31, 2024, we had $939.3 million of cash and cash equivalents. Cash and cash equivalents consist of cash in banks, bank deposits, and money market accounts. In addition, we had $804.1 million of marketable securities, consisting of treasury bills and U.S. government securities, corporate bonds, agency bonds, and commercial paper. Such interest-earning instruments carry a degree of interest rate risk. The primary objectives of our investment activities are the preservation of capital, the fulfillment of liquidity needs, and the fiduciary control of cash. We do not enter into investments for trading or speculative purposes. The effect of a hypothetical 10% change in interest rates would not have had a material impact on our condensed consolidated financial statements for the six months ended July 31, 2024.

Table of Contents

Foreign Currency Exchange Risk

The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while translation of revenue and expenses is based on average monthly rates. Translation adjustments are recorded as a component of accumulated other comprehensive income, and transaction gains and losses are recorded in other income, net on our condensed consolidated financial statements. We have from time to time used foreign currency forward contracts to reduce our potential exposure to currency fluctuations. If we are not able to successfully mitigate the risks associated with currency fluctuations, our results of operations could be adversely affected. The estimated translation impact to our condensed consolidated financial statements of a hypothetical 10% change in foreign currency exchange rates would amount to $25.8 million for the six months ended July 31, 2024. For the six months ended July 31, 2024, approximately 54% of our revenues and approximately 36% of our expenses were denominated in non-U.S. dollar currencies, and we recognized net foreign currency transaction gains of $2.2 million.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. In addition, they are designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") as appropriate to allow timely decisions regarding required disclosure.

Pursuant to in Rules 13(a)-13(e) and 15(d)-15(e) under the Exchange Act, our management, with the participation of our CEO and CFO, performed an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of July 31, 2024.

Changes in Internal Control Over Financial Reporting

During the three months ended July 31, 2024, no change in internal control over financial reporting was identified in connection with the evaluation required by Rule 13a-15(d) and Rule 15d-15(d) of the Exchange Act that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

Our management, including our CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at a reasonable assurance level. However, any control system, no matter how well designed and operated, can only provide reasonable, not absolute, assurance that its objectives will be met. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures and internal control over financial reporting, including resource constraints, errors in judgment, and the possibility that controls and procedures will be circumvented by collusion, by management override, or by mistake. Additionally, the design of any control system is based in part on management assumptions about the likelihood of future events, and there can be no assurance that the system will succeed in achieving its objectives under all potential future scenarios. As a result of these limitations, our management does not expect that our disclosure controls and procedures and internal control over financial reporting will prevent all potential errors or fraud or detect all potential misstatements due to error or fraud.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

Refer to Note 9, Commitments and Contingencies—Litigation, to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for a description of current legal proceedings.

Item 1A. Risk Factors.

Our operations and financial results are subject to various risks and uncertainties, some of which are beyond our control. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risks discussed in the 2024 Form 10-K, including the disclosure under Part I, Item 1A, "Risk Factors,” which are risks we believe could materially affect our business, financial condition and future results. These are not the only risks we face. Other risks and uncertainties we are not currently aware of or that we currently consider immaterial also may materially adversely affect our business, financial condition, and future results. Risks we have identified but currently consider immaterial could still materially adversely affect our business, financial condition, and future results if our assumptions about those risks are incorrect or if circumstances change.

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A of the 2024 Form 10-K except as follows:

We are subject to numerous risks associated with the evolving market for products with AI capabilities.

The markets and use cases for products with AI capabilities have been rapidly evolving, are difficult to predict, and may impact demand for our products, our sales cycles, our ability to forecast results from sales of these products, and the preferences of our customers and potential customers. The significant investments we have made to develop products and software to address what we believe will be increasing demand for AI capabilities may be insufficient, and we face significant hurdles, including whether demand will materialize, whether third-party software providers will develop functionality that allows their software to utilize the AI capabilities of our products, and whether we will be successful in developing, pricing, and packaging products that can compete with offerings by established competitors.

We have invested in an early-stage global foundation model and agentic AI company and we may continue to invest in other potentially disruptive technologies in the future, through various vehicles such as equity or debt investments, joint ventures, or strategic partnerships. Such investments may not produce the expected results, may require more financial resources than anticipated, or may otherwise be unsuccessful, and the value of the investments may decline or be impaired, or our business may be adversely impacted.

Additionally, our use of AI technology in general may subject us to reputational, financial, legal, or regulatory risks. As we continue to incorporate AI technology into our products and services, any failures to address concerns relating to the responsible use of the evolving AI technology in our products and services may cause harm to our reputation or result in financial liability, and as such, may increase our costs to address or mitigate such risks and issues. AI technology may create ethical issues, generate defective algorithms, and present other risks that create challenges with respect to its adoption. In addition, evolving rules, regulations, and industry standards governing AI may require us to expend significant resources to modify, maintain, or align our business practices or products to comply with U.S. and non-U.S. rules and regulations, the nature of which cannot be determined at this time. Several jurisdictions around the globe, including the EU and certain U.S. states, have already proposed or enacted laws governing the development and use of AI, such as the EU's AI Act. U.S. federal agencies are likely to release AI regulations in the near future in light of the Biden administration's October 30, 2023 Executive Order on AI. We expect other jurisdictions will adopt similar laws.

The regulatory environment surrounding the impact of the implementation of AI on our products and services may adversely affect our ability to produce and export products, and as a result, may cause harm to our reputation and result in financial liability.

Table of Contents

Delays or difficulties associated with the design, implementation, or post-implementation use of our new enterprise resource planning ("ERP") system could adversely impact our business, financial condition, and results of operations.

We rely on information systems, particularly ERP technology, to manage our business, summarize our operating and financial results, and provide timely information to our management. We are currently engaged in a multi-year implementation of a new ERP system. This implementation is a complex project with broad scope, in which we have invested and will continue to invest significant financial and human capital. Despite our efforts, we may experience delays, unexpected costs, or other difficulties as the implementation process continues. Further, although we plan to run our existing technology in parallel with the new ERP system for a period of time and to conduct extensive testing to ensure that the new ERP system is operating as intended, post-implementation disruptions to or difficulties in use of the new ERP could require us to incur additional costs, or could impair, among other things, our ability to record sales, process transactions, collect receivables, and produce timely and accurate historical and forecasted financial information, which could adversely impact our business, financial condition, and results of operations. Additionally, if the new ERP system does not ultimately operate as intended, the effectiveness of our internal control over financial reporting could be harmed.

We have undertaken, and may in the future undertake, internal restructuring activities that could result in disruptions to our business or otherwise materially harm our results of operations or financial condition.

From time to time, we have undertaken and may continue to undertake internal restructuring activities in an effort to better align our resources with our business strategy. For example, we initiated a restructuring plan in July 2024. This follows an earlier restructuring plan we initiated in fiscal year 2023 that was completed during the second quarter of fiscal year 2024. We incur substantial costs to implement restructuring plans, and our restructuring activities may subject us to reputational risks and litigation risks and expenses. There can be no assurance that any restructuring activities that we have undertaken or undertake in the future will achieve the cost savings, operating efficiencies, or other benefits that we may initially expect. In addition, restructuring activities may result in loss of institutional knowledge and expertise, attrition beyond our intended reduction in force, or a negative impact on employee morale and productivity or our ability to attract highly skilled employees. Internal restructurings can also require a significant amount of time and focus from management and other employees, which may divert attention from commercial operations. If any internal restructuring activities we have undertaken or undertake in the future fail to achieve some or all of the expected benefits, our business, financial condition, and results of operations could be materially and adversely affected.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Recent Sales of Unregistered Equity Securities

None.

Use of Proceeds from Initial Public Offering of Class A Common Stock

There has been no material change in the planned uses of proceeds from our IPO from those disclosed in the 2024 Form 10-K.

Table of Contents

Issuer Purchase of Equity Securities

The following table presents our Class A common stock repurchase activity under our previously announced stock repurchase program for the three months ended July 31, 2024 (in thousands, except for per share data):


Period	Total Number of Shares Purchased	Average Price Paid Per Share (1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (2)
May 1 - 31	—	$	—	—	$	375,515
June 1 - 30	9,714	$	11.79	9,714	$	260,957
July 1 - 31	6,612	$	12.38	6,612	$	179,095
Total	16,326			16,326

(1) Excludes brokerage commission and 1% excise tax accrued pursuant to the Inflation Reduction Act of 2022.

(2) On September 1, 2023, our board of directors authorized a stock repurchase program which authorized the repurchase from time to time of up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization was scheduled to expire on March 1, 2025. On August 30, 2024, our board of directors authorized an additional $500.0 million of repurchases under the stock repurchase program. As a result of this increase, $554.4 million remained available for repurchases as of August 30, 2024. The current authorization may be suspended or discontinued at any time and does not have a specified expiration date.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Table of Contents

Item 5. Other Information.

During the three months ended July 31, 2024, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions, or written plans for the purchase or sale of our securities as follows:

•On June 6, 2024, Hitesh Ramani, our Chief Accounting Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act to sell 100,000 shares of our Class A common stock through April 15, 2025.

•On June 11, 2024, Brad Brubaker, our Chief Legal Officer and Secretary, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act to sell up to 124,975 shares of our Class A common stock through April 30, 2025, subject to limit prices.

•On June 14, 2024, Ashim Gupta, our CFO, and a family trust adopted a trading plan and to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act to sell up to 659,298 shares of our Class A common stock through January 7, 2025, including up to 289,456 shares of our Class A common stock subject to RSUs previously granted to Mr. Gupta that will vest and be released to Mr. Gupta on or prior to January 1, 2025, subject to limit prices. The actual number of shares underlying 289,456 RSUs that will be released to Mr. Gupta and sold under the Rule 10b5-1 trading plan will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not determinable at this time.

Table of Contents

Item 6. Exhibits.


Exhibit Number						Description
10.1†**						Advisory Agreement between UiPath, Inc. and Robert Enslin, executed May 28, 2024 (incorporated her e in by reference to Exhibit 10.1 to the Registra nt's Quarterly Report on Form 10-Q for the quarterly period ended April 30, 2024, fi led with the SEC on June 3, 2024 ).
31.1						Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2						Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1^						Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2^						Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.SCH						XBRL Taxonomy Extension Schema Document
101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF						XBRL Taxonomy Extension Definition Linkbase Document
101.LAB						XBRL Taxonomy Extension Label Linkbase Document
101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
†						Indicates management contract or compensatory plan.
**						Certain information contained in this agreement has been omitted because it is the type that the registrant treats as private or confidential and/or is not material.
^						The certification furnished in Exhibit 32.1 hereto is deemed to accompany this Quarterly Report on Form 10-Q and is not deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, irrespective of any general incorporation language contained in such filing.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	UiPath, Inc.

Date: September 6, 2024	By:	/s/ Ashim Gupta
		Ashim Gupta
		Chief Financial Officer and Chief Operating Officer (Principal Financial Officer)

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Daniel Dines, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of UiPath, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors:

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: September 6, 2024	By:	/s/ Daniel Dines
		Daniel Dines
		Chief Executive Officer, Founder, and Chairman

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ashim Gupta, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of UiPath, Inc.;

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: September 6, 2024	By:	/s/ Ashim Gupta
		Ashim Gupta
		Chief Financial Officer and Chief Operating Officer (Principal Financial Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of UiPath, Inc. (the “Company”) on Form 10-Q for the quarter ended July 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Daniel Dines, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: September 6, 2024	By:	/s/ Daniel Dines
		Daniel Dines
		Chief Executive Officer, Founder, and Chairman

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of UiPath, Inc. (the “Company”) on Form 10-Q for the quarter ended July 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ashim Gupta, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: September 6, 2024	By:	/s/ Ashim Gupta
		Ashim Gupta
		Chief Financial Officer and Chief Operating Officer (Principal Financial Officer)

Cover - shares	6 Months Ended
Cover - shares	Jul. 31, 2024	Sep. 03, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2024
Document Transition Report	false
Entity File Number	001-40348
Entity Registrant Name	UiPath, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4333187
Entity Address, Address Line One	One Vanderbilt Avenue, 60th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	844
Local Phone Number	432-0455
Title of 12(b) Security	Class A common stock, par value$0.00001 per share
Trading Symbol	PATH
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001734722
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		467,504,776
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		82,452,748

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Current assets
Cash and cash equivalents	$ 939,313	$ 1,061,678
Restricted cash	438	438
Marketable securities	804,061	818,145
Accounts receivable, net of allowance for credit losses of $2,164 and $1,119, respectively	267,706	436,296
Contract assets	101,107	84,197
Deferred contract acquisition costs	76,653	74,678
Prepaid expenses and other current assets	85,056	104,980
Total current assets	2,274,334	2,580,412
Contract assets, non-current	9,232	6,214
Deferred contract acquisition costs, non-current	146,564	154,317
Property and equipment, net	22,040	23,982
Operating lease right-of-use assets	71,033	56,072
Intangible assets, net	11,025	14,704
Goodwill	89,530	89,026
Deferred tax assets	3,763	4,678
Other assets, non-current	73,812	25,353
Total assets	2,701,333	2,954,758
Current liabilities
Accounts payable	9,910	3,447
Accrued expenses and other current liabilities	82,640	83,997
Accrued compensation and employee benefits	77,444	137,442
Deferred revenue	462,509	486,805
Total current liabilities	632,503	711,691
Deferred revenue, non-current	150,346	161,027
Operating lease liabilities, non-current	78,166	58,713
Other liabilities, non-current	6,737	7,213
Total liabilities	867,752	938,644
Commitments and contingencies (Note 9)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding	0	0
Treasury stock, at cost, 23,104 and 5,840 shares, respectively	(322,047)	(102,615)
Additional paid-in capital	4,176,531	4,024,079
Accumulated other comprehensive income	8,105	8,825
Accumulated deficit	(2,029,014)	(1,914,181)
Total stockholders’ equity	1,833,581	2,016,114
Total liabilities and stockholders’ equity	2,701,333	2,954,758
Class A Common Stock
Stockholders' equity
Common stock	5	5
Class B Common Stock
Stockholders' equity
Common stock	$ 1	$ 1

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Accounts receivable, allowance for doubtful accounts	$ 2,164	$ 1,119
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock, at cost (in shares)	23,104	5,840
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	2,000,000	2,000,000
Common stock, shares issued (in shares)	501,162	492,660
Common stock, shares outstanding (in shares)	478,058	486,820
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	115,741	115,741
Common stock, shares issued (in shares)	82,453	82,453
Common stock, shares outstanding (in shares)	82,453	82,453

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Revenue:
Total revenue	$ 316,253	$ 287,310	$ 651,365	$ 576,898
Cost of revenue:
Total cost of revenue	63,320	48,987	118,645	92,654
Gross profit	252,933	238,323	532,720	484,244
Operating expenses:
Sales and marketing	194,330	169,725	374,469	330,131
Research and development	98,433	86,606	184,036	161,948
General and administrative	63,519	59,577	127,029	116,161
Total operating expenses	356,282	315,908	685,534	608,240
Operating loss	(103,349)	(77,585)	(152,814)	(123,996)
Interest income	13,370	13,582	27,200	27,430
Other income, net	7,710	7,472	18,389	11,766
Loss before income taxes	(82,269)	(56,531)	(107,225)	(84,800)
Provision for income taxes	3,828	3,830	7,608	7,462
Net loss	$ (86,097)	$ (60,361)	$ (114,833)	$ (92,262)
Net loss per share, basic (in dollars per share)	$ (0.15)	$ (0.11)	$ (0.20)	$ (0.16)
Net loss per share, diluted (in dollars per share)	$ (0.15)	$ (0.11)	$ (0.20)	$ (0.16)
Weighted-average shares used in computing net loss per share, basic (in shares)	568,042	562,883	568,973	560,422
Weighted-average shares used in computing net loss per share, diluted (in shares)	568,042	562,883	568,973	560,422
Licenses
Revenue:
Total revenue	$ 112,251	$ 119,300	$ 252,379	$ 253,339
Cost of revenue:
Total cost of revenue	2,393	3,008	4,994	5,555
Subscription services
Revenue:
Total revenue	194,673	159,999	379,804	306,351
Cost of revenue:
Total cost of revenue	43,529	26,777	80,283	49,855
Professional services and other
Revenue:
Total revenue	9,329	8,011	19,182	17,208
Cost of revenue:
Total cost of revenue	$ 17,398	$ 19,202	$ 33,368	$ 37,244

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (86,097)	$ (60,361)	$ (114,833)	$ (92,262)
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale marketable securities, net	482	(161)	(29)	(18)
Foreign currency translation adjustments	2,883	1,593	(691)	3,912
Other comprehensive income (loss), net	3,365	1,432	(720)	3,894
Comprehensive loss	$ (82,732)	$ (58,929)	$ (115,553)	$ (88,368)

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023				474,160	82,453
Beginning Balance (in shares) at Jan. 31, 2023						0
Beginning balance at Jan. 31, 2023	$ 1,920,158			$ 5	$ 1	$ 0	$ 3,736,838	$ 7,612	$ (1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				898
Issuance of common stock upon exercise of stock options	1,175						1,175
Issuance of common stock upon settlement of restricted stock units (in shares)				4,246
Tax withholdings on settlement of restricted stock units (in shares)				(1,463)
Tax withholdings on settlement of restricted stock units	(25,697)						(25,697)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	4,215						4,215
Stock-based compensation	85,125						85,125
Other comprehensive income (loss), net	2,462							2,462
Net loss	(31,901)								(31,901)
Ending balance (in shares) at Apr. 30, 2023				478,122	82,453
Ending Balance (in shares) at Apr. 30, 2023						0
Ending balance at Apr. 30, 2023	1,955,537			$ 5	$ 1	$ 0	3,801,656	10,074	(1,856,199)
Beginning balance (in shares) at Jan. 31, 2023				474,160	82,453
Beginning Balance (in shares) at Jan. 31, 2023						0
Beginning balance at Jan. 31, 2023	1,920,158			$ 5	$ 1	$ 0	3,736,838	7,612	(1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Charitable donation of Class A common stock (in shares)				300
Other comprehensive income (loss), net	3,894
Net loss	(92,262)	$ (78,688)	$ (13,574)
Ending balance (in shares) at Jul. 31, 2023				484,128	82,453
Ending Balance (in shares) at Jul. 31, 2023						0
Ending balance at Jul. 31, 2023	1,983,366			$ 5	$ 1	$ 0	3,888,414	11,506	(1,916,560)
Beginning balance (in shares) at Apr. 30, 2023				478,122	82,453
Beginning Balance (in shares) at Apr. 30, 2023						0
Beginning balance at Apr. 30, 2023	1,955,537			$ 5	$ 1	$ 0	3,801,656	10,074	(1,856,199)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,824
Issuance of common stock upon exercise of stock options	2,717						2,717
Issuance of common stock upon settlement of restricted stock units (in shares)				5,026
Tax withholdings on settlement of restricted stock units (in shares)				(1,676)
Tax withholdings on settlement of restricted stock units	(27,420)						(27,420)
Issuance of common stock under employee stock purchase plan (in shares)				832
Issuance of common stock under employee stock purchase plan	9,313						9,313
Stock-based compensation	102,148						102,148
Other comprehensive income (loss), net	1,432							1,432
Net loss	(60,361)	$ (51,519)	$ (8,842)						(60,361)
Ending balance (in shares) at Jul. 31, 2023				484,128	82,453
Ending Balance (in shares) at Jul. 31, 2023						0
Ending balance at Jul. 31, 2023	$ 1,983,366			$ 5	$ 1	$ 0	3,888,414	11,506	(1,916,560)
Beginning balance (in shares) at Jan. 31, 2024		492,660	82,453	492,660	82,453
Beginning Balance (in shares) at Jan. 31, 2024	(5,840)					(5,840)
Beginning balance at Jan. 31, 2024	$ 2,016,114			$ 5	$ 1	$ (102,615)	4,024,079	8,825	(1,914,181)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				1,426
Issuance of common stock upon exercise of stock options	311						311
Issuance of common stock upon settlement of restricted stock units (in shares)				3,843
Tax withholdings on settlement of restricted stock units (in shares)				(1,317)
Tax withholdings on settlement of restricted stock units	(29,944)						(29,944)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	6,564						6,564
Repurchase of Class A common stock (in shares)						(938)
Repurchase of Class A Common Stock	(22,005)					$ (22,005)
Stock-based compensation	88,785						88,785
Other comprehensive income (loss), net	(4,085)							(4,085)
Net loss	(28,736)								(28,736)
Ending balance (in shares) at Apr. 30, 2024				496,893	82,453
Ending Balance (in shares) at Apr. 30, 2024						(6,778)
Ending balance at Apr. 30, 2024	$ 2,027,004			$ 5	$ 1	$ (124,620)	4,089,795	4,740	(1,942,917)
Beginning balance (in shares) at Jan. 31, 2024		492,660	82,453	492,660	82,453
Beginning Balance (in shares) at Jan. 31, 2024	(5,840)					(5,840)
Beginning balance at Jan. 31, 2024	$ 2,016,114			$ 5	$ 1	$ (102,615)	4,024,079	8,825	(1,914,181)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	2,153
Charitable donation of Class A common stock (in shares)				300
Repurchase of Class A common stock (in shares)				(17,300)
Other comprehensive income (loss), net	$ (720)
Net loss	$ (114,833)	$ (98,192)	$ (16,641)
Ending balance (in shares) at Jul. 31, 2024		501,162	82,453	501,162	82,453
Ending Balance (in shares) at Jul. 31, 2024	(23,104)					(23,104)
Ending balance at Jul. 31, 2024	$ 1,833,581			$ 5	$ 1	$ (322,047)	4,176,531	8,105	(2,029,014)
Beginning balance (in shares) at Apr. 30, 2024				496,893	82,453
Beginning Balance (in shares) at Apr. 30, 2024						(6,778)
Beginning balance at Apr. 30, 2024	2,027,004			$ 5	$ 1	$ (124,620)	4,089,795	4,740	(1,942,917)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				727
Issuance of common stock upon exercise of stock options	331						331
Issuance of common stock upon settlement of restricted stock units (in shares)				3,970
Vesting of early exercised stock options	1						1
Tax withholdings on settlement of restricted stock units (in shares)				(1,293)
Tax withholdings on settlement of restricted stock units	(16,727)						(16,727)
Repurchase of Class A common stock (in shares)				(16,300)		(16,326)
Repurchase of Class A Common Stock	(197,427)					$ (197,427)
Issuance of common stock under employee stock purchase plan (in shares)				865
Issuance of common stock under employee stock purchase plan	8,824						8,824
Stock-based compensation	94,307						94,307
Other comprehensive income (loss), net	3,365							3,365
Net loss	$ (86,097)	$ (73,600)	$ (12,497)						(86,097)
Ending balance (in shares) at Jul. 31, 2024		501,162	82,453	501,162	82,453
Ending Balance (in shares) at Jul. 31, 2024	(23,104)					(23,104)
Ending balance at Jul. 31, 2024	$ 1,833,581			$ 5	$ 1	$ (322,047)	$ 4,176,531	$ 8,105	$ (2,029,014)

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Cash flows from operating activities
Net loss	$ (114,833)	$ (92,262)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	9,483	11,160
Amortization of deferred contract acquisition costs	39,392	31,229
Net amortization on marketable securities	(18,527)	(10,745)
Stock-based compensation expense	183,032	187,145
Charitable donation of Class A common stock	6,564	4,215
Non-cash operating lease expense	7,562	6,299
Provision for deferred income taxes	752	(57)
Other non-cash (credits) charges, net	(573)	965
Changes in operating assets and liabilities:
Accounts receivable	165,781	147,725
Contract assets	(19,773)	(9,455)
Deferred contract acquisition costs	(33,898)	(36,389)
Prepaid expenses and other assets	6,314	(6,679)
Accounts payable	6,774	(6,033)
Accrued expenses and other liabilities	7,018	(4,229)
Accrued compensation and employee benefits	(59,799)	(74,184)
Operating lease liabilities, net	(6,983)	(7,532)
Deferred revenue	(31,873)	(29,547)
Net cash provided by operating activities	146,413	111,626
Cash flows from investing activities
Purchases of marketable securities	(697,765)	(709,199)
Maturities of marketable securities	730,337	338,644
Purchases of property and equipment	(2,656)	(2,876)
Purchases of investments	(35,809)	0
Other investing, net	0	2,754
Net cash used in investing activities	(5,893)	(370,677)
Cash flows from financing activities
Repurchases of Class A common stock	(218,752)	0
Proceeds from exercise of stock options	643	3,904
Payments of tax withholdings on net settlement of equity awards	(45,949)	(52,832)
Net receipts (payments) of tax withholdings on sell-to-cover equity award transactions	99	(679)
Proceeds from employee stock purchase plan contributions	8,642	9,643
Payment of deferred consideration related to business acquisition	(5,570)	(5,863)
Net cash used in financing activities	(260,887)	(45,827)
Effect of exchange rate changes	(1,998)	(2,943)
Net decrease in cash, cash equivalents, and restricted cash	(122,365)	(307,821)
Cash, cash equivalents, and restricted cash - beginning of period	1,062,116	1,402,119
Cash, cash equivalents, and restricted cash - end of period	939,751	1,094,298
Supplemental disclosure of cash flow information
Cash paid for interest	309	413
Cash paid for income taxes	12,054	7,234
Supplemental disclosure of non-cash investing and financing activities
Property and equipment purchases included in accounts payable	149	0
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	$ 4,069	$ 2,466

Organization and Description of Business	6 Months Ended
Organization and Description of Business	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our AI-powered UiPath Business Automation Platform offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale.

Summary of Significant Accounting Policies	6 Months Ended
Summary of Significant Accounting Policies	Jul. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies, in the notes to consolidated financial statements included in the 2024 Form 10-K. There have been no significant changes to such policies during the six months ended July 31, 2024. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2024, which are included in the 2024 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the six months ended July 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2025 or for any other future interim or annual period. Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2025, for example, refer to the fiscal year ending January 31, 2025. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions. Foreign Currency The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income, net in the condensed consolidated statements of operations. For the three months ended July 31, 2024 and 2023, we recognized foreign currency transaction losses of $(0.6) million and $(0.6) million, respectively. For the six months ended July 31, 2024 and 2023, we recognized foreign currency transaction gains (losses) of $2.2 million and $(1.4) million, respectively. Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of July 31, 2024 and January 31, 2024, 90% and 91%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints. With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three and six months ended July 31, 2024 and 2023, no single customer accounted for 10% or more of our total revenue. As of July 31, 2024 and January 31, 2024, no single customer accounted for 10% or more of our accounts receivable. Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU No. 2023-09 will require additional tax disclosures, predominantly related to the effective income tax rate reconciliation and income taxes paid. ASU No. 2023-09 will be effective for us for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

Revenue Recognition

6 Months Ended

Jul. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Disaggregation of Revenue

The following tables summarize revenue by geographical region (dollars in thousands):


	Three Months Ended July 31,
	2024				2023
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	150,591	48	%	$	139,718	49	%
Europe, Middle East, and Africa	97,989		31	%	81,009		28	%
Asia-Pacific (2)	67,673		21	%	66,583		23	%
Total revenue	$	316,253	100	%	$	287,310	100	%

(1)Revenue from the U.S. represented 43% and 44% of our total revenues for the three months ended July 31, 2024 and 2023, respectively.

(2)Revenue from Japan represented 9% and 10% of our total revenues for the three months ended July 31, 2024 and 2023, respectively.


	Six Months Ended July 31,
	2024				2023
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	303,702	47	%	$	263,170	46	%
Europe, Middle East, and Africa	202,616		31	%	177,940		31	%
Asia-Pacific (2)	145,047		22	%	135,788		23	%
Total revenue	$	651,365	100	%	$	576,898	100	%

(1)Revenue from the U.S. represented 42% and 41% of our total revenues for the six months ended July 31, 2024 and 2023, respectively.

(2)Revenue from Japan represented 11% and 11% of our total revenues for the six months ended July 31, 2024 and 2023, respectively.

Deferred Revenue

Remaining Performance Obligations

Deferred Contract Acquisition Costs

Marketable Securities

6 Months Ended

Jul. 31, 2024

Investments, Debt and Equity Securities [Abstract]

Marketable Securities

The following is a summary of our marketable securities (in thousands):


	As of July 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	3,896	$	—	$	—	$	3,896
Treasury bills and U.S. government securities(1)	684,481		23		(102)		684,402
Corporate bonds	93,974		—		(39)		93,935

Agency bonds	21,839		—		(11)		21,828
Total marketable securities	$	804,190	$	23	$	(152)	$	804,061
(1) Additional treasury bills with both amortized cost and estimated fair value of $29.9 million are included in cash and cash equivalents due to their original maturity of three months or less.


	As of January 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value

Treasury bills and U.S. government securities	641,263		29		(100)		641,192
Corporate bonds	1,993		—		(2)		1,991

Agency bonds	174,990		—		(28)		174,962
Total marketable securities	$	818,246	$	29	$	(130)	$	818,145

As of July 31, 2024 and January 31, 2024, none of our marketable securities had remaining contractual maturities of one year or more.

Fair Value Measurement

6 Months Ended

Jul. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurement

The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of July 31, 2024 and January 31, 2024 (in thousands):


	As of July 31, 2024
	Level 1		Level 2		Level 3		Total

Money market	$	407,805	$	—	$	—	$	407,805
Treasury bills	29,886		—		—		29,886


Total cash equivalents	437,691		—		—		437,691
Commercial paper	—		3,896		—		3,896
Treasury bills and U.S. government securities	684,402		—		—		684,402
Corporate bonds	—		93,935		—		93,935

Agency bonds	21,828		—		—		21,828
Total marketable securities	706,230		97,831		—		804,061
Other investments carried at fair value	—		—		12,074		12,074
Total	$	1,143,921	$	97,831	$	12,074	$	1,253,826


	As of January 31, 2024
	Level 1		Level 2		Level 3		Total

Money market	$	509,053	$	—	$	—	$	509,053

Total cash equivalents	509,053		—		—		509,053

Treasury bills and U.S. government securities	641,192		—		—		641,192
Corporate bonds	—		1,991		—		1,991

Agency bonds	174,962		—		—		174,962
Total marketable securities	816,154		1,991		—		818,145
Total	$	1,325,207	$	1,991	$	—	$	1,327,198

Intangible Assets and Goodwill

6 Months Ended

Jul. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

Intangible Assets, Net

Acquired intangible assets, net consisted of the following as of July 31, 2024 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,954	$	(19,793)	$	9,161	2.5
Customer relationships	8,312		(7,181)		1,131		1.0
Trade names and trademarks	271		(271)		—		0.0
Other intangibles	1,231		(498)		733		6.7
Total	$	38,768	$	(27,743)	$	11,025

Acquired intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,807	$	(16,881)	$	11,926	2.8
Customer relationships	8,266		(6,306)		1,960		1.3
Trade names and trademarks	272		(266)		6		0.2
Other intangibles	1,231		(419)		812		7.0
Total	$	38,576	$	(23,872)	$	14,704

Expected future amortization expense related to intangible assets was as follows as of July 31, 2024 (in thousands):


	Amount
Remainder of year ending January 31, 2025	$	2,925
Year ending January 31,
2026	4,142
2027	2,478
2028	1,178
2029	101
Thereafter	201
Total	$	11,025

Goodwill

Changes in the carrying amount of goodwill during the six months ended July 31, 2024 were as follows (in thousands):


	Carrying Amount
Balance as of January 31, 2024	$	89,026

Effect of foreign currency translation	504
Balance as of July 31, 2024	$	89,530

Operating Leases

6 Months Ended

Jul. 31, 2024

Leases [Abstract]

Operating Leases

Lease costs are presented below (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Operating lease cost	$	4,086	$	3,228	$	7,562	$	6,299
Short-term lease cost	1,024		1,320		2,147		2,620
Variable lease cost	411		525		934		1,146
Sublease income (1)	—		(533)		—		(1,065)
Total	$	5,521	$	4,540	$	10,643	$	9,000

(1) Included in other income, net in the condensed consolidated statements of operations.

The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:


	As of
	July 31, 2024		January 31, 2024
Weighted-average remaining lease term (years)	10.4		10.7
Weighted-average discount rate	7.7	%	7.1	%

Future undiscounted lease payments for our operating lease liabilities as of July 31, 2024 were as follows (in thousands):


	Amount
Remainder of year ending January 31, 2025	$	2,369
Year ending January 31,
2026	14,504
2027	14,367
2028	12,979
2029	9,661
Thereafter	65,646
Total operating lease payments	119,526
Less: imputed interest	(36,922)
Total operating lease liabilities	$	82,604

As of July 31, 2024, we had non-cancellable commitments in the amount of $0.8 million related to operating leases of real estate facilities that have not yet commenced.

Supplemental cash flow information related to leases for the three and six months ended July 31, 2024 and 2023 was as follows (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Cash paid for amounts included in the measurement of operating lease liabilities	$	3,665	$	3,545	$	7,318	$	6,160
Operating lease ROU assets obtained in exchange for new operating lease liabilities	12,748		2,688		19,792		4,681

Condensed Consolidated Balance Sheet Components

6 Months Ended

Jul. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidated Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of
	July 31, 2024		January 31, 2024
Prepaid expenses and service credits	$	59,363	$	87,781
Other current assets	25,693		17,199
Prepaid expenses and other current assets	$	85,056	$	104,980

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of
	July 31, 2024		January 31, 2024
Computers and equipment	$	23,976	$	23,767
Leasehold improvements	26,262		21,756
Furniture and fixtures	6,931		6,640
Construction in progress	1,727		4,560
Other	644		632
Property and equipment, gross	59,540		57,355
Less: accumulated depreciation	(37,500)		(33,373)
Property and equipment, net	$	22,040	$	23,982

Other Assets, Non-Current

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	As of
	July 31, 2024		January 31, 2024
Accrued expenses	$	34,700	$	18,458
Withholding tax from employee equity transactions	4,100		3,277
Employee stock purchase plan withholdings	3,408		3,618
Payroll taxes and other benefits payable	7,898		3,888
Income taxes payable	7,406		7,140
Value-added taxes payable	655		6,480
Operating lease liabilities, current	4,438		8,357
Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (paid July 29, 2024)	—		5,570
Rebates payable to partners	7,817		7,289
Other	12,218		19,920
Accrued expenses and other current liabilities	$	82,640	$	83,997

Commitments and Contingencies

6 Months Ended

Jul. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Letters of Credit

Indemnification

Workforce Restructuring

For the six months ended July 31, 2024, we incurred $12.6 million of expense associated with employee termination benefits in connection with these restructuring actions.


	Employee Termination Benefits
Accrued restructuring costs as of January 31, 2024(1)	$	335
Restructuring costs incurred during the six months ended July 31, 2024	12,612
Amount paid during the six months ended July 31, 2024	(2,762)
Accrued restructuring costs as of July 31, 2024	$	10,185
(1) Opening balance relates to our fiscal 2023 workforce restructuring actions, which were concluded during the second quarter of fiscal year 2024.

The following table shows the total restructuring costs incurred during the six months ended July 31, 2024 (in thousands):


	Employee Termination Benefits
Cost of subscription services revenue	$	318
Cost of professional services and other revenue	126
Sales and marketing	7,971
Research and development	1,681
General and administrative	2,516
Total	$	12,612

Defined Contribution Plans

Litigation

UiPath and certain of its officers and directors are currently parties to the following litigation matters:

We have not recorded any accrual related to the aforementioned litigation matters as of July 31, 2024, as we believe a loss in these matters is neither probable nor estimable at this time.

Warranty

Other Matters

Non-Cancelable Purchase Obligations

As of July 31, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):


	Amount
Remainder of year ending January 31, 2025	$	21,764
Year ending January 31,
2026	49,559
2027	25,807
2028	8,474
2029	17
Thereafter	1
Total	$	105,622

Stockholders' Equity

6 Months Ended

Jul. 31, 2024

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

Stock Repurchase Program

Charitable Donations of Class A Common Stock

Accumulated Other Comprehensive Income

For the six months ended July 31, 2024 and 2023, changes in the components of accumulated other comprehensive income were as follows (in thousands):


	Foreign Currency Translation Adjustments		Unrealized Loss on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2024	$	8,925	$	(100)	$	8,825
Other comprehensive loss, net of tax	(691)		(29)		(720)
Balance as of July 31, 2024	$	8,234	$	(129)	$	8,105


	Foreign Currency Translation Adjustments		Unrealized Loss on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2023	$	8,231	$	(619)	$	7,612
Other comprehensive income (loss), net of tax	3,912		(18)		3,894
Balance as of July 31, 2023	$	12,143	$	(637)	$	11,506

Equity Incentive Plans and Stock-Based Compensation

6 Months Ended

Jul. 31, 2024

Share-Based Payment Arrangement [Abstract]

Equity Incentive Plans and Stock-Based Compensation

2021 Stock Plan

2021 Employee Stock Purchase Plan

Stock Options

Stock option activity during the six months ended July 31, 2024 was as follows:


	Stock Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2024	11,080	$	3.49	7.8	$	216,010
Granted	1,876	$	0.10
Exercised	(2,153)	$	0.30
Forfeited	(888)	$	14.73
Outstanding as of July 31, 2024	9,915	$	2.53	7.8	$	99,333

Vested and exercisable as of July 31, 2024	4,630	$	5.31	6.6	$	35,540

Restricted Stock Units

RSU activity during the six months ended July 31, 2024 was as follows:


	RSUs (in thousands)	Weighted-Average Grant Date Fair Value Per Share
Unvested as of January 31, 2024	31,272	$	19.89
Granted	12,094	$	19.79
Vested	(7,814)	$	21.38
Forfeited	(6,391)	$	18.97
Unvested as of July 31, 2024	29,161	$	19.65

The fair value of RSUs released during the six months ended July 31, 2024 was $138.5 million.

Employee Stock Purchase Plan Awards

Stock-Based Compensation Associated with Business Acquisition

July 31, 2024, total unrecognized compensation expense related to these shares was $2.5 million, which is to be recognized over a weighted-average remaining period of 1.0 year.

Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Cost of subscription services revenue	$	5,284	$	3,809	$	9,560	$	6,987
Cost of professional services and other revenue	3,015		3,083		5,485		5,782
Sales and marketing	37,473		39,007		73,689		72,130
Research and development	32,654		33,071		61,796		57,844
General and administrative	15,879		23,127		32,502		44,402
Total	$	94,305	$	102,097	$	183,032	$	187,145

Income Taxes	6 Months Ended
Income Taxes	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences. We had a provision for income taxes of $3.8 million, reflecting an effective tax rate of (4.7)%, and $3.8 million, reflecting an effective tax rate of (6.8)%, for the three months ended July 31, 2024 and 2023, respectively. For the three months ended July 31, 2024 and 2023, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets ("DTAs") for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries. We had a provision for income taxes of $7.6 million, reflecting an effective tax rate of (7.1)%, and $7.5 million, reflecting an effective tax rate of (8.8)%, for the six months ended July 31, 2024 and 2023, respectively. For the six months ended July 31, 2024 and 2023, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing DTAs for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries. The realization of tax benefits of net DTAs is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the six months ended July 31, 2024, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. will not be realized. Accordingly, we have recorded a full valuation allowance against U.S., Romania, and U.K. DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance. As of July 31, 2024, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $0.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. Our tax positions are subject to income tax audits in multiple tax jurisdictions globally, with a currently open audit in India, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. Our Romanian subsidiary was subjected to a corporate income tax audit by ANAF for the period from January 2018 through January 2022, which was completed during the three months ended April 30, 2024. Certain deductions have been disallowed, resulting in a proposed reduction of net operating loss carryforwards of approximately $66.7 million. We are in the process of appealing this disallowance. In addition, we have engaged in two bilateral transfer pricing negotiations for our transfer pricing model, one between the U.S. and Romania, and one between Japan and Romania. These negotiations are still underway and the authorities are in the process of determining the cost sharing allocations between the respective countries. At this time, we do not expect any significant changes in the next fiscal quarter based on the current positions undertaken by us. In 2023, Romania adopted an alternative minimum tax that is applicable to all corporate taxpayers, including those reporting a net loss, for tax years commencing after January 1, 2024. As this tax is based on gross receipts, associated expense is included in operating expenses in our condensed consolidated statements of operations, and is not accounted for as income taxes.

Net Loss Per Share

6 Months Ended

Jul. 31, 2024

Earnings Per Share [Abstract]

Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands except per share amounts):


	Three Months Ended July 31,
	2024				2023
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(73,600)	$	(12,497)	$	(51,519)	$	(8,842)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted	485,589		82,453		480,430		82,453
Net loss per share, basic and diluted	$	(0.15)	$	(0.15)	$	(0.11)	$	(0.11)


	Six Months Ended July 31,
	2024				2023
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(98,192)	$	(16,641)	$	(78,688)	$	(13,574)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted	486,520		82,453		477,969		82,453
Net loss per share, basic and diluted	$	(0.20)	$	(0.20)	$	(0.16)	$	(0.16)

Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share were as follows (in thousands):


	Three Months Ended July 31,
	2024		2023
	Class A	Class B	Class A	Class B
Unvested RSUs	33,472	—	40,122	—
Outstanding stock options	10,582	—	14,206	—
Shares subject to repurchase from RSAs and early exercised stock options	16	—	53	—
Shares issuable under ESPP	833	—	680	—
Returnable shares issued in connection with business acquisition	269	—	422	—
Total	45,172	—	55,483	—


	Six Months Ended July 31,
	2024		2023
	Class A	Class B	Class A	Class B
Unvested RSUs	32,858	—	38,760	—
Outstanding stock options	10,762	—	14,047	—
Shares subject to repurchase from RSAs and early exercised stock options	22	—	58	—
Shares issuable under ESPP	762	—	787	—
Returnable shares issued in connection with business acquisition	272	—	425	—
Total	44,676	—	54,077	—

Subsequent Events	6 Months Ended
Subsequent Events	Jul. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On August 30, 2024, our board of directors authorized an additional $500.0 million of repurchases of our outstanding shares of Class A common stock under the stock repurchase program. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. The current authorization may be suspended or discontinued at any time and does not have a specified expiration date.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Jul. 31, 2024	Apr. 30, 2024	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2024	Jul. 31, 2023
Pay vs Performance Disclosure
Net loss	$ (86,097)	$ (28,736)	$ (60,361)	$ (31,901)	$ (114,833)	$ (92,262)

Insider Trading Arrangements	3 Months Ended	6 Months Ended
Insider Trading Arrangements	Jul. 31, 2024 shares	Jul. 31, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Hitesh Ramani [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On June 6, 2024, Hitesh Ramani, our Chief Accounting Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act to sell 100,000 shares of our Class A common stock through April 15, 2025.
Name	Hitesh Ramani
Title	Chief Accounting Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 6, 2024
Expiration Date	April 15, 2025
Arrangement Duration	313 days
Aggregate Available	100,000	100,000
Brad Brubaker [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On June 11, 2024, Brad Brubaker, our Chief Legal Officer and Secretary, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act to sell up to 124,975 shares of our Class A common stock through April 30, 2025, subject to limit prices.
Name	Brad Brubaker
Title	Chief Legal Officer and Secretary
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 11, 2024
Expiration Date	April 30, 2025
Arrangement Duration	323 days
Aggregate Available	124,975	124,975
Ashim Gupta [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On June 14, 2024, Ashim Gupta, our CFO, and a family trust adopted a trading plan and to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act to sell up to 659,298 shares of our Class A common stock through January 7, 2025, including up to 289,456 shares of our Class A common stock subject to RSUs previously granted to Mr. Gupta that will vest and be released to Mr. Gupta on or prior to January 1, 2025, subject to limit prices. The actual number of shares underlying 289,456 RSUs that will be released to Mr. Gupta and sold under the Rule 10b5-1 trading plan will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not determinable at this time.
Name	Ashim Gupta
Title	CFO
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 14, 2024
Expiration Date	January 7, 2025
Arrangement Duration	207 days
Aggregate Available	659,298	659,298

Summary of Significant Accounting Policies (Policies)	6 Months Ended
Summary of Significant Accounting Policies (Policies)	Jul. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2024, which are included in the 2024 Form 10-K. The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation. The results of operations for the six months ended July 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2025 or for any other future interim or annual period.
Fiscal Year	Fiscal Year Our fiscal year ends on January 31. References to fiscal year 2025, for example, refer to the fiscal year ending January 31, 2025.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.
Foreign Currency	Foreign Currency The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income, net in the condensed consolidated statements of operations.
Concentration of Risks	Concentration of Risks Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of July 31, 2024 and January 31, 2024, 90% and 91%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan. The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints. With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU No. 2023-09 will require additional tax disclosures, predominantly related to the effective income tax rate reconciliation and income taxes paid. ASU No. 2023-09 will be effective for us for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

Revenue Recognition (Tables)

6 Months Ended

Jul. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue by Geographical Region

The following tables summarize revenue by geographical region (dollars in thousands):


	Three Months Ended July 31,
	2024				2023
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	150,591	48	%	$	139,718	49	%
Europe, Middle East, and Africa	97,989		31	%	81,009		28	%
Asia-Pacific (2)	67,673		21	%	66,583		23	%
Total revenue	$	316,253	100	%	$	287,310	100	%

(1)Revenue from the U.S. represented 43% and 44% of our total revenues for the three months ended July 31, 2024 and 2023, respectively.

(2)Revenue from Japan represented 9% and 10% of our total revenues for the three months ended July 31, 2024 and 2023, respectively.


	Six Months Ended July 31,
	2024				2023
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	303,702	47	%	$	263,170	46	%
Europe, Middle East, and Africa	202,616		31	%	177,940		31	%
Asia-Pacific (2)	145,047		22	%	135,788		23	%
Total revenue	$	651,365	100	%	$	576,898	100	%

(1)Revenue from the U.S. represented 42% and 41% of our total revenues for the six months ended July 31, 2024 and 2023, respectively.

(2)Revenue from Japan represented 11% and 11% of our total revenues for the six months ended July 31, 2024 and 2023, respectively.

Marketable Securities (Tables)

6 Months Ended

Jul. 31, 2024

Investments, Debt and Equity Securities [Abstract]

Schedule of Marketable Securities

The following is a summary of our marketable securities (in thousands):


	As of July 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	3,896	$	—	$	—	$	3,896
Treasury bills and U.S. government securities(1)	684,481		23		(102)		684,402
Corporate bonds	93,974		—		(39)		93,935

Agency bonds	21,839		—		(11)		21,828
Total marketable securities	$	804,190	$	23	$	(152)	$	804,061
(1) Additional treasury bills with both amortized cost and estimated fair value of $29.9 million are included in cash and cash equivalents due to their original maturity of three months or less.


	As of January 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value

Treasury bills and U.S. government securities	641,263		29		(100)		641,192
Corporate bonds	1,993		—		(2)		1,991

Agency bonds	174,990		—		(28)		174,962
Total marketable securities	$	818,246	$	29	$	(130)	$	818,145

Fair Value Measurement (Tables)

6 Months Ended

Jul. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis

The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of July 31, 2024 and January 31, 2024 (in thousands):


	As of July 31, 2024
	Level 1		Level 2		Level 3		Total

Money market	$	407,805	$	—	$	—	$	407,805
Treasury bills	29,886		—		—		29,886


Total cash equivalents	437,691		—		—		437,691
Commercial paper	—		3,896		—		3,896
Treasury bills and U.S. government securities	684,402		—		—		684,402
Corporate bonds	—		93,935		—		93,935

Agency bonds	21,828		—		—		21,828
Total marketable securities	706,230		97,831		—		804,061
Other investments carried at fair value	—		—		12,074		12,074
Total	$	1,143,921	$	97,831	$	12,074	$	1,253,826


	As of January 31, 2024
	Level 1		Level 2		Level 3		Total

Money market	$	509,053	$	—	$	—	$	509,053

Total cash equivalents	509,053		—		—		509,053

Treasury bills and U.S. government securities	641,192		—		—		641,192
Corporate bonds	—		1,991		—		1,991

Agency bonds	174,962		—		—		174,962
Total marketable securities	816,154		1,991		—		818,145
Total	$	1,325,207	$	1,991	$	—	$	1,327,198

Intangible Assets and Goodwill (Tables)

6 Months Ended

Jul. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets, Net

Acquired intangible assets, net consisted of the following as of July 31, 2024 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,954	$	(19,793)	$	9,161	2.5
Customer relationships	8,312		(7,181)		1,131		1.0
Trade names and trademarks	271		(271)		—		0.0
Other intangibles	1,231		(498)		733		6.7
Total	$	38,768	$	(27,743)	$	11,025

Acquired intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands):


	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,807	$	(16,881)	$	11,926	2.8
Customer relationships	8,266		(6,306)		1,960		1.3
Trade names and trademarks	272		(266)		6		0.2
Other intangibles	1,231		(419)		812		7.0
Total	$	38,576	$	(23,872)	$	14,704

Schedule of Expected Future Amortization Expenses Related to Intangible Assets

Expected future amortization expense related to intangible assets was as follows as of July 31, 2024 (in thousands):


	Amount
Remainder of year ending January 31, 2025	$	2,925
Year ending January 31,
2026	4,142
2027	2,478
2028	1,178
2029	101
Thereafter	201
Total	$	11,025

Schedule of Changes in Carrying Amounts of Goodwill

Changes in the carrying amount of goodwill during the six months ended July 31, 2024 were as follows (in thousands):


	Carrying Amount
Balance as of January 31, 2024	$	89,026

Effect of foreign currency translation	504
Balance as of July 31, 2024	$	89,530

Operating Leases (Tables)

6 Months Ended

Jul. 31, 2024

Leases [Abstract]

Schedule of Lease Costs and Supplemental Cash Flow Information

Lease costs are presented below (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Operating lease cost	$	4,086	$	3,228	$	7,562	$	6,299
Short-term lease cost	1,024		1,320		2,147		2,620
Variable lease cost	411		525		934		1,146
Sublease income (1)	—		(533)		—		(1,065)
Total	$	5,521	$	4,540	$	10,643	$	9,000

(1) Included in other income, net in the condensed consolidated statements of operations.

Supplemental cash flow information related to leases for the three and six months ended July 31, 2024 and 2023 was as follows (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Cash paid for amounts included in the measurement of operating lease liabilities	$	3,665	$	3,545	$	7,318	$	6,160
Operating lease ROU assets obtained in exchange for new operating lease liabilities	12,748		2,688		19,792		4,681

Schedule of Weighted-average Lease Term and Discount Rate

The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:


	As of
	July 31, 2024		January 31, 2024
Weighted-average remaining lease term (years)	10.4		10.7
Weighted-average discount rate	7.7	%	7.1	%

Schedule of Future Undiscounted Lease Payments for Operating Lease Liabilities

Future undiscounted lease payments for our operating lease liabilities as of July 31, 2024 were as follows (in thousands):


	Amount
Remainder of year ending January 31, 2025	$	2,369
Year ending January 31,
2026	14,504
2027	14,367
2028	12,979
2029	9,661
Thereafter	65,646
Total operating lease payments	119,526
Less: imputed interest	(36,922)
Total operating lease liabilities	$	82,604

Condensed Consolidated Balance Sheet Components (Tables)

6 Months Ended

Jul. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	As of
	July 31, 2024		January 31, 2024
Prepaid expenses and service credits	$	59,363	$	87,781
Other current assets	25,693		17,199
Prepaid expenses and other current assets	$	85,056	$	104,980

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of
	July 31, 2024		January 31, 2024
Computers and equipment	$	23,976	$	23,767
Leasehold improvements	26,262		21,756
Furniture and fixtures	6,931		6,640
Construction in progress	1,727		4,560
Other	644		632
Property and equipment, gross	59,540		57,355
Less: accumulated depreciation	(37,500)		(33,373)
Property and equipment, net	$	22,040	$	23,982

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	As of
	July 31, 2024		January 31, 2024
Accrued expenses	$	34,700	$	18,458
Withholding tax from employee equity transactions	4,100		3,277
Employee stock purchase plan withholdings	3,408		3,618
Payroll taxes and other benefits payable	7,898		3,888
Income taxes payable	7,406		7,140
Value-added taxes payable	655		6,480
Operating lease liabilities, current	4,438		8,357
Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (paid July 29, 2024)	—		5,570
Rebates payable to partners	7,817		7,289
Other	12,218		19,920
Accrued expenses and other current liabilities	$	82,640	$	83,997

Commitments and Contingencies (Tables)

6 Months Ended

Jul. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of Accrued Restructuring Costs


	Employee Termination Benefits
Accrued restructuring costs as of January 31, 2024(1)	$	335
Restructuring costs incurred during the six months ended July 31, 2024	12,612
Amount paid during the six months ended July 31, 2024	(2,762)
Accrued restructuring costs as of July 31, 2024	$	10,185
(1) Opening balance relates to our fiscal 2023 workforce restructuring actions, which were concluded during the second quarter of fiscal year 2024.

Schedule of Restructuring Costs

The following table shows the total restructuring costs incurred during the six months ended July 31, 2024 (in thousands):


	Employee Termination Benefits
Cost of subscription services revenue	$	318
Cost of professional services and other revenue	126
Sales and marketing	7,971
Research and development	1,681
General and administrative	2,516
Total	$	12,612

Schedule of Non-Cancelable Purchase Obligations

As of July 31, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):


	Amount
Remainder of year ending January 31, 2025	$	21,764
Year ending January 31,
2026	49,559
2027	25,807
2028	8,474
2029	17
Thereafter	1
Total	$	105,622

Stockholders' Equity (Tables)

6 Months Ended

Jul. 31, 2024

Equity [Abstract]

Schedule of Changes in Components of Accumulated Other Comprehensive Income

For the six months ended July 31, 2024 and 2023, changes in the components of accumulated other comprehensive income were as follows (in thousands):


	Foreign Currency Translation Adjustments		Unrealized Loss on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2024	$	8,925	$	(100)	$	8,825
Other comprehensive loss, net of tax	(691)		(29)		(720)
Balance as of July 31, 2024	$	8,234	$	(129)	$	8,105


	Foreign Currency Translation Adjustments		Unrealized Loss on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2023	$	8,231	$	(619)	$	7,612
Other comprehensive income (loss), net of tax	3,912		(18)		3,894
Balance as of July 31, 2023	$	12,143	$	(637)	$	11,506

Equity Incentive Plans and Stock-Based Compensation (Tables)

6 Months Ended

Jul. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

Stock option activity during the six months ended July 31, 2024 was as follows:


	Stock Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2024	11,080	$	3.49	7.8	$	216,010
Granted	1,876	$	0.10
Exercised	(2,153)	$	0.30
Forfeited	(888)	$	14.73
Outstanding as of July 31, 2024	9,915	$	2.53	7.8	$	99,333

Vested and exercisable as of July 31, 2024	4,630	$	5.31	6.6	$	35,540

Schedule of RSU Activity

RSU activity during the six months ended July 31, 2024 was as follows:


	RSUs (in thousands)	Weighted-Average Grant Date Fair Value Per Share
Unvested as of January 31, 2024	31,272	$	19.89
Granted	12,094	$	19.79
Vested	(7,814)	$	21.38
Forfeited	(6,391)	$	18.97
Unvested as of July 31, 2024	29,161	$	19.65

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):


	Three Months Ended July 31,				Six Months Ended July 31,
	2024		2023		2024		2023
Cost of subscription services revenue	$	5,284	$	3,809	$	9,560	$	6,987
Cost of professional services and other revenue	3,015		3,083		5,485		5,782
Sales and marketing	37,473		39,007		73,689		72,130
Research and development	32,654		33,071		61,796		57,844
General and administrative	15,879		23,127		32,502		44,402
Total	$	94,305	$	102,097	$	183,032	$	187,145

Net Loss Per Share (Tables)

6 Months Ended

Jul. 31, 2024

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands except per share amounts):


	Three Months Ended July 31,
	2024				2023
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(73,600)	$	(12,497)	$	(51,519)	$	(8,842)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted	485,589		82,453		480,430		82,453
Net loss per share, basic and diluted	$	(0.15)	$	(0.15)	$	(0.11)	$	(0.11)


	Six Months Ended July 31,
	2024				2023
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(98,192)	$	(16,641)	$	(78,688)	$	(13,574)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted	486,520		82,453		477,969		82,453
Net loss per share, basic and diluted	$	(0.20)	$	(0.20)	$	(0.16)	$	(0.16)

Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share

Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share were as follows (in thousands):


	Three Months Ended July 31,
	2024		2023
	Class A	Class B	Class A	Class B
Unvested RSUs	33,472	—	40,122	—
Outstanding stock options	10,582	—	14,206	—
Shares subject to repurchase from RSAs and early exercised stock options	16	—	53	—
Shares issuable under ESPP	833	—	680	—
Returnable shares issued in connection with business acquisition	269	—	422	—
Total	45,172	—	55,483	—


	Six Months Ended July 31,
	2024		2023
	Class A	Class B	Class A	Class B
Unvested RSUs	32,858	—	38,760	—
Outstanding stock options	10,762	—	14,047	—
Shares subject to repurchase from RSAs and early exercised stock options	22	—	58	—
Shares issuable under ESPP	762	—	787	—
Returnable shares issued in connection with business acquisition	272	—	425	—
Total	44,676	—	54,077	—

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gain (losses)	$ (0.6)	$ (0.6)	$ 2.2	$ (1.4)
United States, European Union Countries and Japan \| Geographic Concentration Risk \| Cash and Cash Equivalents
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage			90.00%		91.00%

Revenue Recognition - Disaggregation of Revenue by Geographical Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Disaggregation of Revenue [Line Items]
Amount	$ 316,253	$ 287,310	$ 651,365	$ 576,898
Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100.00%	100.00%	100.00%	100.00%
Americas
Disaggregation of Revenue [Line Items]
Amount	$ 150,591	$ 139,718	$ 303,702	$ 263,170
Americas \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	48.00%	49.00%	47.00%	46.00%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Amount	$ 97,989	$ 81,009	$ 202,616	$ 177,940
Europe, Middle East, and Africa \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	31.00%	28.00%	31.00%	31.00%
Asia-Pacific
Disaggregation of Revenue [Line Items]
Amount	$ 67,673	$ 66,583	$ 145,047	$ 135,788
Asia-Pacific \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	21.00%	23.00%	22.00%	23.00%
United States \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	43.00%	44.00%	42.00%	41.00%
Japan \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	9.00%	10.00%	11.00%	11.00%

Revenue Recognition - Deferred Revenue and Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized			$ 309,000	$ 254,800
Amortization of deferred contract acquisition costs	$ 20,900	$ 17,100	$ 39,392	$ 31,229

Revenue Recognition - Remaining Performance Obligations (Details) $ in Millions	Jul. 31, 2024 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 1,081.3
Billed Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	612.9
Unbilled Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 468.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-08-01
Disaggregation of Revenue [Line Items]
Remaining performance obligations, percentage	63.00%
Remaining performance obligations, period	12 months

Marketable Securities - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 804,190	$ 818,246
Gross Unrealized Gains	23	29
Gross Unrealized Losses	(152)	(130)
Estimated Fair Value	804,061	818,145
Cash and cash equivalents, amortized cost	939,313	1,061,678
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	3,896
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	3,896
Treasury bills and U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	684,481	641,263
Gross Unrealized Gains	23	29
Gross Unrealized Losses	(102)	(100)
Estimated Fair Value	684,402	641,192
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	93,974	1,993
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(39)	(2)
Estimated Fair Value	93,935	1,991
Agency bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	21,839	174,990
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(11)	(28)
Estimated Fair Value	21,828	$ 174,962
Treasury bills
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents, fair value	29,900
Cash and cash equivalents, amortized cost	$ 29,900

Marketable Securities - Additional Information (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Marketable securities with contractual maturities of one year or more	$ 0.0	$ 0.0
Interest receivable	$ 3.6	$ 3.3

Fair Value Measurement (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	$ 804,061	$ 818,145
Treasury bills
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	29,900
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	93,935	1,991
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	3,896
Treasury bills and U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	684,402	641,192
Agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	21,828	174,962
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	437,691	509,053
Total marketable securities	804,061	818,145
Other investments carried at fair value	12,074
Total	1,253,826	1,327,198
Recurring \| Money market
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	407,805	509,053
Recurring \| Treasury bills
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	29,886
Recurring \| Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	93,935	1,991
Recurring \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	3,896
Recurring \| Treasury bills and U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	684,402	641,192
Recurring \| Agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	21,828	174,962
Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	437,691	509,053
Total marketable securities	706,230	816,154
Other investments carried at fair value	0
Total	1,143,921	1,325,207
Recurring \| Level 1 \| Money market
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	407,805	509,053
Recurring \| Level 1 \| Treasury bills
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	29,886
Recurring \| Level 1 \| Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0	0
Recurring \| Level 1 \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0
Recurring \| Level 1 \| Treasury bills and U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	684,402	641,192
Recurring \| Level 1 \| Agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	21,828	174,962
Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Total marketable securities	97,831	1,991
Other investments carried at fair value	0
Total	97,831	1,991
Recurring \| Level 2 \| Money market
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Recurring \| Level 2 \| Treasury bills
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0
Recurring \| Level 2 \| Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	93,935	1,991
Recurring \| Level 2 \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	3,896
Recurring \| Level 2 \| Treasury bills and U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0	0
Recurring \| Level 2 \| Agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0	0
Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Total marketable securities	0	0
Other investments carried at fair value	12,074
Total	12,074	0
Recurring \| Level 3 \| Money market
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Recurring \| Level 3 \| Treasury bills
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0
Recurring \| Level 3 \| Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0	0
Recurring \| Level 3 \| Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0
Recurring \| Level 3 \| Treasury bills and U.S. government securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	0	0
Recurring \| Level 3 \| Agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total marketable securities	$ 0	$ 0

Intangible Assets and Goodwill - Summary of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 38,768	$ 38,576
Accumulated Amortization	(27,743)	(23,872)
Intangible Assets, Net	11,025	14,704
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	28,954	28,807
Accumulated Amortization	(19,793)	(16,881)
Intangible Assets, Net	$ 9,161	$ 11,926
Weighted-Average Remaining Useful Life (years)	2 years 6 months	2 years 9 months 18 days
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 8,312	$ 8,266
Accumulated Amortization	(7,181)	(6,306)
Intangible Assets, Net	$ 1,131	$ 1,960
Weighted-Average Remaining Useful Life (years)	1 year	1 year 3 months 18 days
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 271	$ 272
Accumulated Amortization	(271)	(266)
Intangible Assets, Net	$ 0	$ 6
Weighted-Average Remaining Useful Life (years)	0 years	2 months 12 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 1,231	$ 1,231
Accumulated Amortization	(498)	(419)
Intangible Assets, Net	$ 733	$ 812
Weighted-Average Remaining Useful Life (years)	6 years 8 months 12 days	7 years

Intangible Assets and Goodwill - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of acquired intangible assets	$ 1.8	$ 2.2	$ 3.8	$ 4.3

Intangible Assets and Goodwill - Summary of Expected Future Amortization Expenses Related to Intangible Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of year ending January 31, 2025	$ 2,925
2026	4,142
2027	2,478
2028	1,178
2029	101
Thereafter	201
Intangible Assets, Net	$ 11,025	$ 14,704

Intangible Assets and Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2024 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 89,026
Effect of foreign currency translation	504
Ending balance	$ 89,530

Operating Leases - Additional Information (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Lessee, Lease, Description [Line Items]
Non-cancellable commitments for operating leases that have not yet commenced	$ 800
Current operating lease liabilities	$ 4,438	$ 8,357
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Minimum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	14 years

Operating Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Leases [Abstract]
Operating lease cost	$ 4,086	$ 3,228	$ 7,562	$ 6,299
Short-term lease cost	1,024	1,320	2,147	2,620
Variable lease cost	411	525	934	1,146
Sublease income	0	(533)	0	(1,065)
Total	$ 5,521	$ 4,540	$ 10,643	$ 9,000

Operating Leases - Weighted Average Lease Term and Discount Rate (Details)	Jul. 31, 2024	Jan. 31, 2024
Leases [Abstract]
Weighted-average remaining lease term (years)	10 years 4 months 24 days	10 years 8 months 12 days
Weighted-average discount rate	7.70%	7.10%

Operating Leases - Summary of Future Undiscounted Lease Payments for Operating Lease Liabilities (Details) $ in Thousands	Jul. 31, 2024 USD ($)
Leases [Abstract]
Remainder of year ending January 31, 2025	$ 2,369
2026	14,504
2027	14,367
2028	12,979
2029	9,661
Thereafter	65,646
Total operating lease payments	119,526
Less: imputed interest	(36,922)
Total operating lease liabilities	$ 82,604

Operating Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 3,665	$ 3,545	$ 7,318	$ 6,160
Operating lease ROU assets obtained in exchange for new operating lease liabilities	$ 12,748	$ 2,688	$ 19,792	$ 4,681

Condensed Consolidated Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses and service credits	$ 59,363	$ 87,781
Other current assets	25,693	17,199
Prepaid expenses and other current assets	$ 85,056	$ 104,980

Condensed Consolidated Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 59,540	$ 57,355
Less: accumulated depreciation	(37,500)	(33,373)
Property and equipment, net	22,040	23,982
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	23,976	23,767
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	26,262	21,756
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,931	6,640
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,727	4,560
Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 644	$ 632

Condensed Consolidated Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 2.3	$ 2.8	$ 4.6	$ 5.8
Equity investments without readily determinable fair values	25.4		25.4		$ 1.5
Convertible bonds	$ 12.1		$ 12.1

Condensed Consolidated Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 34,700	$ 18,458
Withholding tax from employee equity transactions	4,100	3,277
Employee stock purchase plan withholdings	3,408	3,618
Payroll taxes and other benefits payable	7,898	3,888
Income taxes payable	7,406	7,140
Value-added taxes payable	655	6,480
Operating lease liabilities, current	4,438	8,357
Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (paid July 29, 2024)	0	5,570
Rebates payable to partners	7,817	7,289
Other	12,218	19,920
Accrued expenses and other current liabilities	$ 82,640	$ 83,997

Commitments and Contingencies - Additional Information (Details) $ in Thousands		3 Months Ended		6 Months Ended
	Aug. 19, 2024 motion	Jul. 31, 2024 USD ($)	Jul. 31, 2023 USD ($)	Jul. 31, 2024 USD ($)	Jul. 31, 2023 USD ($)	Jan. 31, 2024 USD ($)
Other Commitments [Line Items]
Letters of credit outstanding		$ 2,800		$ 2,800		$ 2,600
Restructuring costs incurred				12,612
Defined contribution plan, contribution cost		4,000	$ 3,500	10,200	$ 9,100
Subsequent Event \| Steiner and Brunozzi Actions
Other Commitments [Line Items]
Number of motions filed \| motion	2
Litigation Matters
Other Commitments [Line Items]
Loss contingency accrual		0		0
Product Liability Contingencies
Other Commitments [Line Items]
Loss contingency accrual		0		0
Other Matters
Other Commitments [Line Items]
Loss contingency accrual		$ 0		$ 0

Commitments and Contingencies - Accrued Restructuring Costs (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2024 USD ($)
Restructuring Reserve [Roll Forward]
Accrued restructuring costs, beginning balance	$ 335
Restructuring costs incurred	12,612
Amount paid	(2,762)
Accrued restructuring costs, ending balance	$ 10,185

Commitments and Contingencies - Restructuring Costs (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	$ 12,612
Cost of subscription services revenue
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	318
Cost of professional services and other revenue
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	126
Sales and marketing
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	7,971
Research and development
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	1,681
General and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred	$ 2,516

Commitments and Contingencies - Schedule of Non-Cancelable Purchase Obligations (Details) $ in Thousands	Jul. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of year ending January 31, 2025	$ 21,764
2026	49,559
2027	25,807
2028	8,474
2029	17
Thereafter	1
Total	$ 105,622

Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands	1 Months Ended	3 Months Ended			6 Months Ended
	Sep. 03, 2024	Jul. 31, 2024	Apr. 30, 2024	Apr. 30, 2023	Jul. 31, 2024	Jul. 31, 2023	Aug. 30, 2024	Sep. 01, 2023
Class of Stock [Line Items]
Excise tax		$ 700,000			$ 700,000
Charitable contribution recorded as expense					$ 6,564,000	$ 4,215,000
Common Stock \| Class A Common Stock
Class of Stock [Line Items]
Repurchase amount authorized								$ 500,000,000
Repurchase of common stock (in shares)		16,300			17,300
Average price of common stock repurchased (in dollar per share)		$ 12.05			$ 12.67
Common stock shares reserved to fund social impact and environmental, social and governance initiatives (in shares)		2,800			2,800
Common stock contributed as a charitable donation (in shares)			281	281	300	300
Common Stock \| Class A Common Stock \| Subsequent Event
Class of Stock [Line Items]
Repurchase amount authorized							$ 500,000,000.0
Repurchase of common stock (in shares)	10,700
Average price of common stock repurchased (in dollar per share)	$ 11.67

Stockholders' Equity - Summary of Changes In Components of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2024	Apr. 30, 2024	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2024	Jul. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 2,027,004	$ 2,016,114	$ 1,955,537	$ 1,920,158	$ 2,016,114	$ 1,920,158
Other comprehensive income (loss), net of tax	3,365	(4,085)	1,432	2,462	(720)	3,894
Ending balance	1,833,581	2,027,004	1,983,366	1,955,537	1,833,581	1,983,366
Accumulated Other Comprehensive Income
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	4,740	8,825	10,074	7,612	8,825	7,612
Other comprehensive income (loss), net of tax	3,365	(4,085)	1,432	2,462
Ending balance	8,105	4,740	11,506	10,074	8,105	11,506
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		8,925		8,231	8,925	8,231
Other comprehensive income (loss), net of tax					(691)	3,912
Ending balance	8,234		12,143		8,234	12,143
Unrealized Loss on Marketable Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (100)		$ (619)	(100)	(619)
Other comprehensive income (loss), net of tax					(29)	(18)
Ending balance	$ (129)		$ (637)		$ (129)	$ (637)

Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		1 Months Ended	6 Months Ended
	Jul. 29, 2022	Apr. 22, 2021	Jul. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of stock options granted (in dollars per share)			$ 20.47
Intrinsic value of stock options exercised			$ 40.9
Cost not yet recognized for unvested options			$ 101.7
Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period			1 year
Stock issued at closing subject to clawback provisions (in shares)	0.4
Unrecognized compensation expense			$ 2.5
Shares issuable under ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)		15.5
Period of shares automatically increase		10 years
Percentage of total number of shares		1.00%
Number of shares authorized (in shares)			27.2
Weighted-average remaining period			4 months 24 days
Shares purchased (in shares)			0.9
Purchase price (in dollars per share)			$ 10.21
Unrecognized compensation expense			$ 2.4
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period			2 years 1 month 6 days
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period			2 years 2 months 12 days
Fair value of RSUs vested			$ 138.5
Unrecognized compensation expense			$ 531.5
Class A Common Stock \| Shares issuable under ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock, offering date, percent of market price		85.00%
Purchase price of common stock, purchase date, percent of market price		85.00%
2021 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of shares automatically increase		10 years
Percentage of total number of shares		5.00%
2021 Stock Plan \| Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)			202.2

Equity Incentive Plans and Stock-Based Compensation - Summary of Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended	12 Months Ended
	Jul. 31, 2024 USD ($) $ / shares shares	Jan. 31, 2024 USD ($) $ / shares shares
Stock Options
Outstanding, beginning balance (in shares) \| shares	11,080
Granted (in shares) \| shares	1,876
Exercised (in shares) \| shares	(2,153)
Forfeited (in shares) \| shares	(888)
Outstanding, ending balance (in shares) \| shares	9,915	11,080
Weighted-Average Exercise Price
Outstanding, beginning balance (in dollars per share) \| $ / shares	$ 3.49
Granted (in dollars per share) \| $ / shares	0.10
Exercised (in dollars per share) \| $ / shares	0.30
Forfeited (in dollars per share) \| $ / shares	14.73
Outstanding, ending balance (in dollars per share) \| $ / shares	$ 2.53	$ 3.49
Outstanding, Weighted-Average Remaining Contractual Life (years)	7 years 9 months 18 days	7 years 9 months 18 days
Outstanding, Aggregate Intrinsic Value \| $	$ 99,333	$ 216,010
Vested and exercisable, Stock Options (in shares) \| shares	4,630
Vested and exercisable, Weighted-Average Exercise Price (in dollars per share) \| $ / shares	$ 5.31
Vested and exercisable, Weighted-Average Remaining Contractual Life (years)	6 years 7 months 6 days
Vested and exercisable, Aggregate Intrinsic Value \| $	$ 35,540

Equity Incentive Plans and Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units shares in Thousands	6 Months Ended
	Jul. 31, 2024 $ / shares shares
RSUs
Unvested, beginning balance (in shares) \| shares	31,272
Granted (in shares) \| shares	12,094
Vested (in shares) \| shares	(7,814)
Forfeited (in shares) \| shares	(6,391)
Unvested, ending balance (in shares) \| shares	29,161
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in dollars per share) \| $ / shares	$ 19.89
Granted (in dollars per share) \| $ / shares	19.79
Vested (in dollars per share) \| $ / shares	21.38
Forfeited (in dollars per share) \| $ / shares	18.97
Unvested, ending balance (in dollars per share) \| $ / shares	$ 19.65

Equity Incentive Plans and Stock-based Compensation - Summary of Stock-Based Compensation Expense in Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 94,305	$ 102,097	$ 183,032	$ 187,145
Cost of revenue \| Subscription services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	5,284	3,809	9,560	6,987
Cost of revenue \| Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	3,015	3,083	5,485	5,782
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	37,473	39,007	73,689	72,130
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	32,654	33,071	61,796	57,844
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 15,879	$ 23,127	$ 32,502	$ 44,402

Income Taxes (Details) $ in Thousands	3 Months Ended		6 Months Ended
Income Taxes (Details) $ in Thousands	Jul. 31, 2024 USD ($) negotiation	Jul. 31, 2023 USD ($)	Jul. 31, 2024 USD ($) negotiation	Jul. 31, 2023 USD ($)
Income Tax Examination [Line Items]
Provision for income taxes	$ 3,828	$ 3,830	$ 7,608	$ 7,462
Effective tax rate	(4.70%)	(6.80%)	(7.10%)	(8.80%)
Unrecognized tax benefits which would impact the effective tax rate if recognized	$ 2,300		$ 2,300
Liability pertaining to uncertain tax positions	$ 500		$ 500
Number of bilateral transfer pricing negotiations \| negotiation	2		2
Romania \| Subsidiaries
Income Tax Examination [Line Items]
Proposed reduction in net operating loss carryforwards	$ 66,700		$ 66,700

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Jul. 31, 2024	Apr. 30, 2024	Jul. 31, 2023	Apr. 30, 2023	Jul. 31, 2024	Jul. 31, 2023
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (86,097)	$ (28,736)	$ (60,361)	$ (31,901)	$ (114,833)	$ (92,262)
Denominator:
Weighted-average shares used in computing net loss per share, basic (in shares)	568,042		562,883		568,973	560,422
Net loss per share, basic (in dollars per share)	$ (0.15)		$ (0.11)		$ (0.20)	$ (0.16)
Denominator:
Weighted-average shares used in computing net loss per share, diluted (in shares)	568,042		562,883		568,973	560,422
Net loss per share, diluted (in dollars per share)	$ (0.15)		$ (0.11)		$ (0.20)	$ (0.16)
Class A
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (73,600)		$ (51,519)		$ (98,192)	$ (78,688)
Denominator:
Weighted-average shares used in computing net loss per share, basic (in shares)	485,589		480,430		486,520	477,969
Net loss per share, basic (in dollars per share)	$ (0.15)		$ (0.11)		$ (0.20)	$ (0.16)
Denominator:
Weighted-average shares used in computing net loss per share, diluted (in shares)	485,589		480,430		486,520	477,969
Net loss per share, diluted (in dollars per share)	$ (0.15)		$ (0.11)		$ (0.20)	$ (0.16)
Class B
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (12,497)		$ (8,842)		$ (16,641)	$ (13,574)
Denominator:
Weighted-average shares used in computing net loss per share, basic (in shares)	82,453		82,453		82,453	82,453
Net loss per share, basic (in dollars per share)	$ (0.15)		$ (0.11)		$ (0.20)	$ (0.16)
Denominator:
Weighted-average shares used in computing net loss per share, diluted (in shares)	82,453		82,453		82,453	82,453
Net loss per share, diluted (in dollars per share)	$ (0.15)		$ (0.11)		$ (0.20)	$ (0.16)

Net Loss Per Share - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Class A
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	45,172	55,483	44,676	54,077
Class A \| Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	33,472	40,122	32,858	38,760
Class A \| Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	10,582	14,206	10,762	14,047
Class A \| Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	16	53	22	58
Class A \| Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	833	680	762	787
Class A \| Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	269	422	272	425
Class B
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B \| Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B \| Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B \| Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B \| Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0
Class B \| Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0	0	0

Subsequent Events (Details) - Class A Common Stock - Common Stock - USD ($)	Aug. 30, 2024	Sep. 01, 2023
Subsequent Event [Line Items]
Repurchase amount authorized		$ 500,000,000
Subsequent Event
Subsequent Event [Line Items]
Repurchase amount authorized	$ 500,000,000.0

UiPath (NYSE:PATH)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

UiPath (NYSE:PATH)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

PATH UiPath Inc

News UiPath Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

PATH UiPath Inc

News UiPath Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen